COVID-19
Regístrese
metricas
covid
Neurología (English Edition)
Buscar en
Neurología (English Edition)
Toda la web
Inicio Neurología (English Edition) Clinical, molecular, and pharmacological aspects of FMR1-related disorders
Journal Information
Back to article

Statistics

Follow this link to access the full text of the article

Review article
Clinical, molecular, and pharmacological aspects of FMR1-related disorders
Aspectos clínicos, moleculares y farmacológicos en los trastornos asociados a gen 1 del retraso mental del X frágil
A. Pugin1, V. Faundes1,
Corresponding author
vfaundes@inta.cl

Corresponding author.
, L. Santa María, B. Curotto, S. Aliaga, I. Salas, P. Soto, P. Bravo, M.I. Peña, M.A. Alliende
Laboratorio de Genética y Enfermedades Metabólicas, Instituto de Nutrición y Tecnología de los Alimentos (INTA), Universidad de Chile, Santiago, Chile
Read
6515
Times
was read the article
1269
Total PDF
5246
Total HTML
Share statistics
 array:25 [
  "pii" => "S2173580816301249"
  "issn" => "21735808"
  "doi" => "10.1016/j.nrleng.2014.10.018"
  "estado" => "S300"
  "fechaPublicacion" => "2017-05-01"
  "aid" => "690"
  "copyright" => "Sociedad Española de Neurología"
  "copyrightAnyo" => "2014"
  "documento" => "article"
  "crossmark" => 1
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "ssu"
  "cita" => "Neurologia. 2017;32:241-52"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:2 [
    "total" => 2196
    "formatos" => array:3 [
      "EPUB" => 60
      "HTML" => 1676
      "PDF" => 460
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:20 [
      "pii" => "S0213485314002321"
      "issn" => "02134853"
      "doi" => "10.1016/j.nrl.2014.10.009"
      "estado" => "S300"
      "fechaPublicacion" => "2017-05-01"
      "aid" => "690"
      "copyright" => "Sociedad Española de Neurología"
      "documento" => "article"
      "crossmark" => 1
      "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
      "subdocumento" => "ssu"
      "cita" => "Neurologia. 2017;32:241-52"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 3653
        "formatos" => array:3 [
          "EPUB" => 70
          "HTML" => 2359
          "PDF" => 1224
        ]
      ]
      "es" => array:13 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Revisi&#243;n</span>"
        "titulo" => "Aspectos cl&#237;nicos&#44; moleculares y farmacol&#243;gicos en los trastornos asociados a gen 1 del retraso mental del X fr&#225;gil"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "tieneResumen" => array:2 [
          0 => "es"
          1 => "en"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "241"
            "paginaFinal" => "252"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Clinical&#44; molecular&#44; and pharmacological aspects of <span class="elsevierStyleItalic">FMR1</span> related disorders"
          ]
        ]
        "contieneResumen" => array:2 [
          "es" => true
          "en" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:7 [
            "identificador" => "fig0005"
            "etiqueta" => "Figura 1"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr1.jpeg"
                "Alto" => 887
                "Ancho" => 2332
                "Tamanyo" => 154006
              ]
            ]
            "descripcion" => array:1 [
              "es" => "<p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Familia y su genealog&#237;a con espectro de des&#243;rdenes relacionados con el SXF&#46; <span class="elsevierStyleItalic">A&#41;</span> En la genealog&#237;a&#44; los individuos <span class="elsevierStyleSmallCaps">I</span>&#46;2 y <span class="elsevierStyleSmallCaps">II</span>&#46;2 presentan una premutaci&#243;n de 83 y 96 tripletes CGG y manifestaron insuficiencia ov&#225;rica prematura a los 35 y 36 a&#241;os&#44; respectivamente&#46; Los individuos <span class="elsevierStyleSmallCaps">III</span>&#46;2 y <span class="elsevierStyleSmallCaps">III</span>&#46;3 son hermanos que presentan una mutaci&#243;n completa de 370 y 570 tripletes CGG&#44; y fueron diagnosticados con SXF a los 5 y un a&#241;o&#44; respectivamente&#46; <span class="elsevierStyleItalic">B&#41;</span> Fotos de los integrantes de la familia descrita y su respectiva ubicaci&#243;n en la genealog&#237;a&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "A&#46; Pugin, V&#46; Faundes, L&#46; Santa Mar&#237;a, B&#46; Curotto, S&#46; Aliaga, I&#46; Salas, P&#46; Soto, P&#46; Bravo, M&#46;I&#46; Pe&#241;a, M&#46;A&#46; Alliende"
            "autores" => array:10 [
              0 => array:2 [
                "nombre" => "A&#46;"
                "apellidos" => "Pugin"
              ]
              1 => array:2 [
                "nombre" => "V&#46;"
                "apellidos" => "Faundes"
              ]
              2 => array:2 [
                "nombre" => "L&#46;"
                "apellidos" => "Santa Mar&#237;a"
              ]
              3 => array:2 [
                "nombre" => "B&#46;"
                "apellidos" => "Curotto"
              ]
              4 => array:2 [
                "nombre" => "S&#46;"
                "apellidos" => "Aliaga"
              ]
              5 => array:2 [
                "nombre" => "I&#46;"
                "apellidos" => "Salas"
              ]
              6 => array:2 [
                "nombre" => "P&#46;"
                "apellidos" => "Soto"
              ]
              7 => array:2 [
                "nombre" => "P&#46;"
                "apellidos" => "Bravo"
              ]
              8 => array:2 [
                "nombre" => "M&#46;I&#46;"
                "apellidos" => "Pe&#241;a"
              ]
              9 => array:2 [
                "nombre" => "M&#46;A&#46;"
                "apellidos" => "Alliende"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S2173580816301249"
          "doi" => "10.1016/j.nrleng.2014.10.018"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => false
            "ES2" => false
            "LATM" => false
          ]
          "gratuito" => false
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173580816301249?idApp=UINPBA00004N"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213485314002321?idApp=UINPBA00004N"
      "url" => "/02134853/0000003200000004/v1_201704150014/S0213485314002321/v1_201704150014/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:20 [
    "pii" => "S2173580816301213"
    "issn" => "21735808"
    "doi" => "10.1016/j.nrleng.2014.11.003"
    "estado" => "S300"
    "fechaPublicacion" => "2017-05-01"
    "aid" => "701"
    "copyright" => "Sociedad Espa&#241;ola de Neurolog&#237;a"
    "documento" => "article"
    "crossmark" => 1
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "ssu"
    "cita" => "Neurologia. 2017;32:253-63"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:2 [
      "total" => 3173
      "formatos" => array:3 [
        "EPUB" => 67
        "HTML" => 2198
        "PDF" => 908
      ]
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Review article</span>"
      "titulo" => "Benefits of music therapy on behaviour disorders in subjects diagnosed with dementia&#58; A systematic review"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "253"
          "paginaFinal" => "263"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Beneficios de la musicoterapia en las alteraciones conductuales de la demencia&#46; Revisi&#243;n sistem&#225;tica"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 2675
              "Ancho" => 1623
              "Tamanyo" => 248207
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Procedure for selecting articles&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "M&#46; G&#243;mez-Romero, M&#46; Jim&#233;nez-Palomares, J&#46; Rodr&#237;guez-Mansilla, A&#46; Flores-Nieto, E&#46;M&#46; Garrido-Ardila, M&#46;V&#46; Gonz&#225;lez-L&#243;pez-Arza"
          "autores" => array:6 [
            0 => array:2 [
              "nombre" => "M&#46;"
              "apellidos" => "G&#243;mez-Romero"
            ]
            1 => array:2 [
              "nombre" => "M&#46;"
              "apellidos" => "Jim&#233;nez-Palomares"
            ]
            2 => array:2 [
              "nombre" => "J&#46;"
              "apellidos" => "Rodr&#237;guez-Mansilla"
            ]
            3 => array:2 [
              "nombre" => "A&#46;"
              "apellidos" => "Flores-Nieto"
            ]
            4 => array:2 [
              "nombre" => "E&#46;M&#46;"
              "apellidos" => "Garrido-Ardila"
            ]
            5 => array:2 [
              "nombre" => "M&#46;V&#46;"
              "apellidos" => "Gonz&#225;lez-L&#243;pez-Arza"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0213485314002485"
        "doi" => "10.1016/j.nrl.2014.11.001"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213485314002485?idApp=UINPBA00004N"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173580816301213?idApp=UINPBA00004N"
    "url" => "/21735808/0000003200000004/v1_201704190057/S2173580816301213/v1_201704190057/en/main.assets"
  ]
  "itemAnterior" => array:20 [
    "pii" => "S217358081730055X"
    "issn" => "21735808"
    "doi" => "10.1016/j.nrleng.2015.11.006"
    "estado" => "S300"
    "fechaPublicacion" => "2017-05-01"
    "aid" => "822"
    "copyright" => "Sociedad Espa&#241;ola de Neurolog&#237;a"
    "documento" => "article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "fla"
    "cita" => "Neurologia. 2017;32:236-40"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 750
      "formatos" => array:3 [
        "EPUB" => 56
        "HTML" => 493
        "PDF" => 201
      ]
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>"
      "titulo" => "Influence of chewing behaviour on memory and spatial learning in albino BALB&#47;c mice"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "236"
          "paginaFinal" => "240"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Influencia del tipo de masticaci&#243;n sobre la memoria y el aprendizaje espacial en ratones albinos de la cepa BALB&#47;c"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 857
              "Ancho" => 1656
              "Tamanyo" => 95474
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Escape latency &#40;time to find the hidden platform&#41; by day during acquisition phase&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "E&#46;E&#46; Aguirre Siancas"
          "autores" => array:1 [
            0 => array:2 [
              "nombre" => "E&#46;E&#46;"
              "apellidos" => "Aguirre Siancas"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0213485315002649"
        "doi" => "10.1016/j.nrl.2015.11.008"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213485315002649?idApp=UINPBA00004N"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S217358081730055X?idApp=UINPBA00004N"
    "url" => "/21735808/0000003200000004/v1_201704190057/S217358081730055X/v1_201704190057/en/main.assets"
  ]
  "en" => array:20 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Review article</span>"
    "titulo" => "Clinical&#44; molecular&#44; and pharmacological aspects of <span class="elsevierStyleItalic">FMR1</span>-related disorders"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "241"
        "paginaFinal" => "252"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "A&#46; Pugin, V&#46; Faundes, L&#46; Santa Mar&#237;a, B&#46; Curotto, S&#46; Aliaga, I&#46; Salas, P&#46; Soto, P&#46; Bravo, M&#46;I&#46; Pe&#241;a, M&#46;A&#46; Alliende"
        "autores" => array:10 [
          0 => array:3 [
            "nombre" => "A&#46;"
            "apellidos" => "Pugin"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">1</span>"
                "identificador" => "fn0005"
              ]
            ]
          ]
          1 => array:4 [
            "nombre" => "V&#46;"
            "apellidos" => "Faundes"
            "email" => array:1 [
              0 => "vfaundes&#64;inta&#46;cl"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">1</span>"
                "identificador" => "fn0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          2 => array:2 [
            "nombre" => "L&#46;"
            "apellidos" => "Santa Mar&#237;a"
          ]
          3 => array:2 [
            "nombre" => "B&#46;"
            "apellidos" => "Curotto"
          ]
          4 => array:2 [
            "nombre" => "S&#46;"
            "apellidos" => "Aliaga"
          ]
          5 => array:2 [
            "nombre" => "I&#46;"
            "apellidos" => "Salas"
          ]
          6 => array:2 [
            "nombre" => "P&#46;"
            "apellidos" => "Soto"
          ]
          7 => array:2 [
            "nombre" => "P&#46;"
            "apellidos" => "Bravo"
          ]
          8 => array:2 [
            "nombre" => "M&#46;I&#46;"
            "apellidos" => "Pe&#241;a"
          ]
          9 => array:2 [
            "nombre" => "M&#46;A&#46;"
            "apellidos" => "Alliende"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Laboratorio de Gen&#233;tica y Enfermedades Metab&#243;licas&#44; Instituto de Nutrici&#243;n y Tecnolog&#237;a de los Alimentos &#40;INTA&#41;&#44; Universidad de Chile&#44; Santiago&#44; Chile"
            "identificador" => "aff0005"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Aspectos cl&#237;nicos&#44; moleculares y farmacol&#243;gicos en los trastornos asociados a gen 1 del retraso mental del X fr&#225;gil"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0010"
        "etiqueta" => "Figure 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 1211
            "Ancho" => 3002
            "Tamanyo" => 195677
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Genomic location and role of <span class="elsevierStyleItalic">FMR1</span> and <span class="elsevierStyleItalic">FMR1-AS1</span>&#46; The grey bar represents the genomic position &#40;in kilobases &#91;kb&#93;&#41; of both genes on the X chromosome from the P-terminal end&#46; The black square represents the CpG island involved in silencing both genes in patients with FM&#46; The arrows placed next to the CpG island and each gene represent the direction of transcription&#46; The vertical lines in <span class="elsevierStyleItalic">FMR1</span> represent the exons of this gene&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Around 1&#37; to 3&#37; of the world&#39;s population has intellectual disability &#40;ID&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Fragile X syndrome &#40;FXS&#41; is the most frequent cause of hereditary ID in men<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> and the main monogenic disorder associated with autism&#46;<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> FXS affects one in 4000 men and one in 8000 women<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a>&#59; however&#44; it may be more frequent if we consider mild ID and behaviour disorders&#46;<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> Nearly half of the cases of X-linked ID correspond to FXS&#46;<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">FXS has an X-linked dominant inheritance pattern and incomplete penetrance&#46; It belongs to a group of disorders associated with mutations in the fragile X mental retardation 1 gene &#40;<span class="elsevierStyleItalic">FMR1</span>&#41;&#44; called fragile X-associated disorders &#40;FXAD&#41;&#44; which include fragile X-associated tremor&#47;ataxia syndrome &#40;FXTAS&#41; and fragile X-associated primary ovarian insufficiency &#40;FXPOI&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">FXS is clinically characterised by ID and such physical features as large protruding ears&#44; hyperextensible joints&#44; and flat feet&#46;<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> Men usually display strabismus&#44; elongated face&#44; prominent jaw&#44; pectus excavatum&#44; mitral valve prolapse&#44; and macroorchidism after the age of 8&#46;<a class="elsevierStyleCrossRefs" href="#bib0040"><span class="elsevierStyleSup">8&#44;9</span></a> However&#44; around 30&#37; of the patients do not present either classic phenotypic traits or a family history of ID&#59; rather&#44; they display symptoms resembling language delay or attention-deficit&#47;hyperactivity disorder &#40;ADHD&#41;&#44; which delays and hinders diagnosis&#46;<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">Symptoms of cognitive impairment appear early and are accompanied by psychomotor retardation&#44;<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">10</span></a> repetitive movements&#44; unusual postures&#44; poor visual contact&#44; and social isolation&#46;<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">11</span></a> Cognitive impairment&#44; language delays&#44; and adjustment disorders are more severe in the 30&#37; of children with autistic features&#46;<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">12</span></a> In some cases&#44; psychomotor retardation may be mild&#59; some children may even display normal psychomotor development initially&#44; and psychomotor retardation may manifest as a learning disorder at a later stage&#46;<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">13</span></a> Around 85&#37; of men and 25&#37; to 30&#37; of women with FXS have an IQ below 70&#59; more women than men display average or borderline intellectual functioning&#46;<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">14</span></a> Most patients develop oral language and acquire general knowledge&#44; and they are able to perform daily living activities&#46;<a class="elsevierStyleCrossRefs" href="#bib0075"><span class="elsevierStyleSup">15&#44;16</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">Some 13&#37; to 18&#37; of men and 4&#37; of women with FXS present epilepsy in the form of generalised or partial complex seizures&#46;<a class="elsevierStyleCrossRefs" href="#bib0085"><span class="elsevierStyleSup">17&#44;18</span></a> Epilepsy is 3 times more frequent in patients with FXS with autistic features&#46;<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">17</span></a></p><p id="par0030" class="elsevierStylePara elsevierViewall">Patients with FXS also display emotional disorders&#44; including anxiety and hyperactivity&#59; they may also show irritability&#44; inflexibility&#44; and aggressiveness&#46;<a class="elsevierStyleCrossRefs" href="#bib0095"><span class="elsevierStyleSup">19&#44;20</span></a> Emotional disorders&#44; especially depression&#44; anxiety&#44; and shyness&#44; are more frequent in women&#46;<a class="elsevierStyleCrossRef" href="#bib0105"><span class="elsevierStyleSup">21</span></a></p><p id="par0035" class="elsevierStylePara elsevierViewall">Some patients have a similar phenotype to that of Prader-Willi syndrome&#58; traits include ID&#44; obesity&#44; and delayed puberty&#44; which may be associated with autism&#59; patients with FXS do not have hypogonadism&#46;<a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">22</span></a></p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Mutations in the fragile X mental retardation 1 gene and associated disorders</span><p id="par0040" class="elsevierStylePara elsevierViewall">In more than 98&#37; of the cases&#44; FXS is caused by a full mutation &#40;FM&#41; due to the expansion of the CGG triplet &#40;&#62;200 repeats&#41; in the 5&#8242; untranslated region of the <span class="elsevierStyleItalic">FMR1</span> gene&#44; at the FRAXA locus on Xq27&#46;3&#46;<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">23</span></a></p><p id="par0045" class="elsevierStylePara elsevierViewall">Healthy individuals have between 4 and 45 CGG repeats in this region&#44; which keeps it stable during DNA replication&#46; Expansions containing more than 50 repeats make the region less stable&#44; and may result in an FM in the following generations&#46;<a class="elsevierStyleCrossRef" href="#bib0120"><span class="elsevierStyleSup">24</span></a></p><p id="par0050" class="elsevierStylePara elsevierViewall">The FM causes hypermethylation of the cytosine-phosphate-guanine &#40;CpG&#41; island located in the promoter region of the <span class="elsevierStyleItalic">FMR1</span> gene&#44; leading to conformational changes in chromatin&#44; which becomes more compact&#46; Chromatin condensation leads to complete or nearly complete inhibition of gene transcription&#44; low or null levels of messenger ribonucleic acid &#40;mRNA&#41;&#44; and a significant decrease in or complete absence of the fragile X mental retardation protein &#40;FMRP&#41;&#46;<a class="elsevierStyleCrossRefs" href="#bib0125"><span class="elsevierStyleSup">25&#44;26</span></a> However&#44; <span class="elsevierStyleItalic">FMR1</span> gene silencing has recently been found to be caused by the expanded mRNA of the gene via hybridisation between the complementary portions of CGG repeats&#44; forming a RNA&#8211;DNA complex and preventing gene expression&#46;<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">27</span></a></p><p id="par0055" class="elsevierStylePara elsevierViewall">Although less frequently&#44; FXS may also be caused by a point mutation&#44; a deletion of the <span class="elsevierStyleItalic">FMR1</span> gene or its promoter&#44;<a class="elsevierStyleCrossRef" href="#bib0140"><span class="elsevierStyleSup">28</span></a> or short CGG repeat tracts &#40;premutation &#91;PM&#93;&#41; which is able to cause low levels of FMRP and thus ID&#46;<a class="elsevierStyleCrossRefs" href="#bib0145"><span class="elsevierStyleSup">29&#44;30</span></a></p><p id="par0060" class="elsevierStylePara elsevierViewall">The phenotypic differences observed between women with FM&#44; as well as between men and women with FM&#44; are explained by the different levels of FMRP expression and non-random inactivation of the mutant X chromosome&#46; Women with preferential inactivation of the X chromosome have more marked ID and low levels of FMRP<a class="elsevierStyleCrossRefs" href="#bib0155"><span class="elsevierStyleSup">31&#44;32</span></a>&#59; their physical and neuropsychiatric phenotype is similar to that in men&#44; although less severe&#46;</p><p id="par0065" class="elsevierStylePara elsevierViewall">Expansion of the CGG triplet to between 55 and 200 repeats&#44; called PM&#44; is a condition associated with instability during replication&#44; and especially in female gametogenesis&#46; In the general population&#44; it has an incidence of one in 113 to 259 women and one in 260 to 813 men&#46;<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> PM does not affect expression of the FMRP substantially&#59; however&#44; expansions of more than 100 CGG repeats frequently yield an FM and FXS in the next generation&#46;<a class="elsevierStyleCrossRef" href="#bib0145"><span class="elsevierStyleSup">29</span></a></p><p id="par0070" class="elsevierStylePara elsevierViewall">PM carriers&#44; especially men&#44; show mild cognitive impairment and behaviour disorders&#46;<a class="elsevierStyleCrossRef" href="#bib0165"><span class="elsevierStyleSup">33</span></a> Clinical impairment is associated with toxicity caused by high levels of mRNA of the <span class="elsevierStyleItalic">FMR1</span> gene&#46;<a class="elsevierStyleCrossRefs" href="#bib0040"><span class="elsevierStyleSup">8&#44;34</span></a> PM is also associated with FXPOI &#40;20&#37; of female carriers&#41;&#44; which manifests as cessation of menstrual periods before reaching the age of 40&#44; and FXTAS in men &#40;40&#37;&#41; and women &#40;8&#37;&#8211;16&#37;&#41; in adulthood&#46;<a class="elsevierStyleCrossRefs" href="#bib0175"><span class="elsevierStyleSup">35&#44;36</span></a> The diagnostic criteria of FXRAS are well established&#59; although they are currently being revised&#44; they are very useful for establishing a diagnosis of definitive&#44; probable&#44; or possible FXTAS &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">37</span></a> Since 2&#37; to 4&#37; of men with late-onset cerebellar ataxia &#40;starting after 50&#41; may be carriers of a PM&#44; we recommend studying the number of CGG repetitions in <span class="elsevierStyleItalic">FMR1</span> in all patients older than 50 who display these symptoms&#46;<a class="elsevierStyleCrossRefs" href="#bib0190"><span class="elsevierStyleSup">38&#44;39</span></a> Male and female carriers of the PM are more frequently affected by autoimmune disorders&#44; including hypothyroidism and fibromyalgia&#46;<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">37</span></a></p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0075" class="elsevierStylePara elsevierViewall">Expansion of CGG repeats is mitotically unstable and favours somatic heterogeneity and presence of mosaic mutations&#46; Mosaic carriers have FM alleles and PM alleles &#40;12&#37; of the patients with FXS&#41;&#46;<a class="elsevierStyleCrossRefs" href="#bib0025"><span class="elsevierStyleSup">5&#44;30</span></a> Patients may also display mosaic methylation patterns&#59; this term refers to the co-presence of alleles with hypermethylated FM and demethylated alleles expanded to the PM and&#47;or FM ranges &#40;6&#37; of the patients&#41;&#46; Mosaic mutation carriers display varying levels of FMRP expression and a higher IQ&#46;<a class="elsevierStyleCrossRefs" href="#bib0070"><span class="elsevierStyleSup">14&#44;30</span></a></p><p id="par0080" class="elsevierStylePara elsevierViewall">It is also important to highlight that CGG repetitions may be interrupted by AGG triplets&#44; and the quantity and position of these triplets are important for replicative stability and therefore affect the probability of expansion in the next generation&#46; In fact&#44; the risk of expansion to an FM in a child of a PM carrier mother decreases by 60&#37; when the mother presents 2 AGG interruptions within a total repeat length of 70 to 80 CGG repeats&#44; compared to mothers with no interruptions within the same range&#46;<a class="elsevierStyleCrossRef" href="#bib0200"><span class="elsevierStyleSup">40</span></a></p><p id="par0085" class="elsevierStylePara elsevierViewall">Lastly&#44; expansions ranging from 45 to 54 CGG repeats are intermediate &#40;also called &#8216;grey zone&#8217;&#41; and combine normal and PM alleles&#46; Grey-zone expansions are not clearly associated with a specific phenotype&#46; They may however expand to an FM after 2 generations&#59; carriers would have a slightly increased risk of developing FXTAS and&#47;or FXPOI&#46;<a class="elsevierStyleCrossRefs" href="#bib0185"><span class="elsevierStyleSup">37&#44;41</span></a> Thus&#44; the wide spectrum of disorders and symptoms associated with the mutations of the <span class="elsevierStyleItalic">FMR1</span> gene lead families to display different genotypic and phenotypic manifestations in successive generations &#40;<a class="elsevierStyleCrossRef" href="#fig0005">Fig&#46; 1</a> and <a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>&#41;&#46;<a class="elsevierStyleCrossRefs" href="#bib0210"><span class="elsevierStyleSup">42&#44;43</span></a></p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><elsevierMultimedia ident="tbl0010"></elsevierMultimedia></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Neurobiology</span><p id="par0095" class="elsevierStylePara elsevierViewall">The <span class="elsevierStyleItalic">FMR1</span> gene has recently been found to act via 2 mechanisms&#58; the best known of these is associated with its protein product&#44; FMRP&#44; whereas the second mechanism is linked to another gene product&#44; long non-coding RNA &#40;lncRNA&#41; <span class="elsevierStyleItalic">FMR4</span> or <span class="elsevierStyleItalic">FMR1-AS1</span>&#46; LncRNA are genes coding for RNA that participate in transcriptional regulation of other genes&#44; which can be positive or negative&#46;<a class="elsevierStyleCrossRefs" href="#bib0220"><span class="elsevierStyleSup">44&#44;45</span></a> The promoter of <span class="elsevierStyleItalic">FMR1</span> codes for the <span class="elsevierStyleItalic">FMR4</span> gene in antisense orientation&#59; this gene overlaps the CGG repeat region and the CpG island&#46; As occurs with <span class="elsevierStyleItalic">FMR1</span>&#44; <span class="elsevierStyleItalic">FMR4</span> is silenced in patients with FM and upregulated in PM carriers &#40;<a class="elsevierStyleCrossRef" href="#fig0010">Fig&#46; 2</a>&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0225"><span class="elsevierStyleSup">45</span></a></p><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0100" class="elsevierStylePara elsevierViewall">FMRP&#44; with a maximum of 631 aminoacids&#44; has 2 RNA-binding motifs&#44; a nuclear localisation signal&#44; a nuclear export signal&#44; and 2 protein&#8211;protein interaction domains&#46;<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">46</span></a> FMRP expression levels vary depending on the tissue and the type of cell within a tissue&#46; In humans&#44; for example&#44; this protein is widely expressed in the epithelium and the central nervous system&#46; Within the central nervous system&#44; FMRP is expressed in the brainstem&#44; the structures arising from the forebrain&#44; and the cerebellum&#59; expression is more marked in neurons than in glial cells&#46; Lastly&#44; within neurons&#44; FMRP is more abundant in the soma&#44; proximal dendrites&#44; and synapses&#46;<a class="elsevierStyleCrossRef" href="#bib0235"><span class="elsevierStyleSup">47</span></a></p><p id="par0105" class="elsevierStylePara elsevierViewall">Regarding FMRP function&#44; several pathways used by this protein to regulate neuronal synapsis and the expression of other genes have been described &#40;<a class="elsevierStyleCrossRef" href="#fig0015">Fig&#46; 3</a>&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">48</span></a> Under normal conditions&#44; FMRP binds to a wide range of mRNA targets&#44;<a class="elsevierStyleCrossRef" href="#bib0245"><span class="elsevierStyleSup">49</span></a> interacts with the 80S ribosome&#44;<a class="elsevierStyleCrossRef" href="#bib0250"><span class="elsevierStyleSup">50</span></a> and decreases ribosomal protein S6 kinase 1 &#40;S6K1&#41; activity&#46;<a class="elsevierStyleCrossRef" href="#bib0245"><span class="elsevierStyleSup">49</span></a> This prevents the translation of different synaptic proteins including the amyloid precursor protein &#40;APP&#41;&#44; the striatal-enriched protein tyrosine phosphatase &#40;STEP&#41;&#44; the activity-regulated cytoskeleton-associated protein &#40;Arc&#41;&#44; and matrix metalloproteinase 9 &#40;MMP-9&#41;&#46;<a class="elsevierStyleCrossRefs" href="#bib0240"><span class="elsevierStyleSup">48&#44;51&#44;52</span></a> These proteins promote internalisation of AMPA receptors&#44; long-term depression &#40;LTD&#41; in the hippocampus and cerebellum&#44; and tissue remodelling at the synaptic level&#44; while decreasing long-term potentiation &#40;LTP&#41; in the hippocampus&#44; cortex&#44; and amygdalae&#46;<a class="elsevierStyleCrossRefs" href="#bib0240"><span class="elsevierStyleSup">48&#44;49&#44;51</span></a> In addition&#44; FMRP promotes the expression of GABA<span class="elsevierStyleInf">A</span> receptors and glutamic acid decarboxylase &#40;GAD&#41;&#44; the rate-limiting enzyme for GABA synthesis&#46;<a class="elsevierStyleCrossRefs" href="#bib0240"><span class="elsevierStyleSup">48&#44;53</span></a> This means that FMRP participates in dendritic spine maturation&#44; synaptogenesis&#44;<a class="elsevierStyleCrossRef" href="#bib0270"><span class="elsevierStyleSup">54</span></a> and dendritic transport and transport regulation of proteins&#46;<a class="elsevierStyleCrossRef" href="#bib0275"><span class="elsevierStyleSup">55</span></a> Likewise&#44; FMRP acts as a translational repressor at synapses&#44; regulating mRNA levels of proteins involved in synaptic structure and function&#44;<a class="elsevierStyleCrossRef" href="#bib0280"><span class="elsevierStyleSup">56</span></a> and it plays a crucial role in the formation of regulated mRNA patterns at the subcellular level during development&#46;<a class="elsevierStyleCrossRef" href="#bib0285"><span class="elsevierStyleSup">57</span></a></p><elsevierMultimedia ident="fig0015"></elsevierMultimedia><p id="par0110" class="elsevierStylePara elsevierViewall">A lack of FMRP results in a wide range of alterations in different neurotransmitter systems&#44; the most important and most studied alteration being dysregulation of glutamatergic pathways&#44; especially via metabotropic glutamate receptors &#40;mGluR&#41; and their downstream proteins&#46; A loss in the regulatory function of FMRP results in overexpression of APP&#44; STEP&#44; Arc&#44; and MMP-9&#59; these are downstream effectors of the mGluR pathway &#40;<a class="elsevierStyleCrossRef" href="#fig0015">Fig&#46; 3</a>&#41;&#46;<a class="elsevierStyleCrossRefs" href="#bib0240"><span class="elsevierStyleSup">48&#44;51</span></a> Glutamatergic pathway overactivation is also due to lack of counterregulation in the GABA pathway due to GABA<span class="elsevierStyleInf">A</span> receptor underexpression and decreased GABA synthesis&#46;<a class="elsevierStyleCrossRef" href="#bib0265"><span class="elsevierStyleSup">53</span></a> This system also inhibits glutamate release&#58; a lack of FMRP indirectly results in increased mGluR activation&#46;<a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">48</span></a> In addition&#44; mGluR also lead to decreased activity of adenylyl cyclase &#40;AC&#41;<a class="elsevierStyleCrossRef" href="#bib0290"><span class="elsevierStyleSup">58</span></a> and the subsequent decrease in GABA release&#46; Lastly&#44; the endocannabinoid and acetylcholine systems are also involved in increased activation of the glutamatergic pathway as they interact with mTOR and ERK proteins&#59; these are downstream mGluR transduction proteins which are activated by cannabinoid receptors &#40;CBR&#41; and muscarinic acetylcholine receptors &#40;mAChR&#41; &#40;<a class="elsevierStyleCrossRef" href="#fig0015">Fig&#46; 3</a>&#41;&#46;<a class="elsevierStyleCrossRefs" href="#bib0240"><span class="elsevierStyleSup">48&#44;59</span></a> The above yields weak synaptic connections<a class="elsevierStyleCrossRefs" href="#bib0300"><span class="elsevierStyleSup">60&#8211;63</span></a> and greater susceptibility to seizures&#46;<a class="elsevierStyleCrossRef" href="#bib0320"><span class="elsevierStyleSup">64</span></a></p><p id="par0115" class="elsevierStylePara elsevierViewall">In the PM range&#44; <span class="elsevierStyleItalic">FMR1</span> is transcribed efficiently and FMRP expression is nearly normal&#44; whereas mRNA translation is poor and compensated with higher levels of mRNA &#40;a 5- to 8-fold increase&#41;&#46;<a class="elsevierStyleCrossRefs" href="#bib0070"><span class="elsevierStyleSup">14&#44;34</span></a> Thus&#44; ubiquitin-positive inclusions accumulate in the nuclei of neurons and glial cells<a class="elsevierStyleCrossRef" href="#bib0325"><span class="elsevierStyleSup">65</span></a> containing expanded <span class="elsevierStyleItalic">FMR1</span> mRNA and sequestered RNA-binding proteins&#44; which affects the function of these proteins and causes neurodegeneration&#46;<a class="elsevierStyleCrossRef" href="#bib0330"><span class="elsevierStyleSup">66</span></a> In humans&#44; the number and size of inclusions increase with age and disease progression&#46;<a class="elsevierStyleCrossRef" href="#bib0335"><span class="elsevierStyleSup">67</span></a> Additionally&#44; mitochondrial dysfunction has been found in fibroblasts and brain samples from PM carriers&#44; which results in increased oxidative stress and lower expression of mitochondrial proteins&#46;<a class="elsevierStyleCrossRef" href="#bib0340"><span class="elsevierStyleSup">68</span></a></p><p id="par0120" class="elsevierStylePara elsevierViewall">The role of <span class="elsevierStyleItalic">FMR1-AS1</span> in the pathogenesis of FXS is not well understood&#46; Khalil et al&#46;<a class="elsevierStyleCrossRef" href="#bib0345"><span class="elsevierStyleSup">69</span></a> showed that partial silencing of <span class="elsevierStyleItalic">FMR4</span> resulted in alterations in the cell cycle and increased apoptosis but had no impact on <span class="elsevierStyleItalic">FMR1</span> expression and vice versa&#44; which suggests that <span class="elsevierStyleItalic">FMR1</span> has an independent mechanism&#46; Many questions regarding the function of <span class="elsevierStyleItalic">FMR1</span> and <span class="elsevierStyleItalic">FMR1-AS1</span> must still be answered &#40;<a class="elsevierStyleCrossRef" href="#fig0010">Fig&#46; 2</a>&#41;&#46; Nevertheless&#44; we may conclude that FXS arises due to lack of expression of both genes&#44; whereas disorders associated with PM are due to <span class="elsevierStyleItalic">FMR1</span> and <span class="elsevierStyleItalic">FMR1-AS1</span> mRNA overexpression&#44; which leads to cell degeneration&#46;</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Confirmation of diagnosis</span><p id="par0125" class="elsevierStylePara elsevierViewall">Tests for detecting <span class="elsevierStyleItalic">FMR1</span> mutations are sensitive and specific for both patients manifesting the disease and asymptomatic carriers of the mutation&#46; These tests are conducted on DNA extracted from a blood sample&#59; the gene is analysed directly to determine the number of CGG repeats and methylation status of the locus&#46;<a class="elsevierStyleCrossRefs" href="#bib0350"><span class="elsevierStyleSup">70&#44;71</span></a></p><p id="par0130" class="elsevierStylePara elsevierViewall">Numerous molecular methods for analysing mutations at the FRAXA locus are currently in use&#58; &#40;1&#41; Techniques based on PCR &#40;polymerase chain reaction&#41; are usually fast&#44; simple&#44; and inexpensive&#44; especially when used to test men only&#46; These techniques can also determine the exact size of the alleles in the normal&#44; grey-zone&#44; PM&#44; and FM ranges&#44; even in women&#46;<a class="elsevierStyleCrossRefs" href="#bib0360"><span class="elsevierStyleSup">72&#44;73</span></a> However&#44; these results must be confirmed by Southern blot analysis&#46;<a class="elsevierStyleCrossRef" href="#bib0350"><span class="elsevierStyleSup">70</span></a> &#40;2&#41; Southern blot provides a direct analysis of the FRAXA locus and the <span class="elsevierStyleItalic">FMR1</span> gene and determines the size of the expansion and the gene&#39;s methylation status&#59; these data are used to determine the level of FMRP expression&#46; These techniques are currently available in Chile&#44; although costs are not covered by health insurance providers &#40;<a class="elsevierStyleCrossRef" href="#fig0020">Fig&#46; 4</a>&#41;&#46;<a class="elsevierStyleCrossRefs" href="#bib0355"><span class="elsevierStyleSup">71&#44;74</span></a> &#40;3&#41; Real-time quantitative PCR-based techniques and methylation specific-quantitative melt analysis &#40;MS-QMA&#41; have recently been developed&#46; These techniques determine the methylation status of other CpG loci within <span class="elsevierStyleItalic">FMR1</span>&#44; and their results are correlated with the level of FMRP expression and the patients&#8217; cognitive status&#46;<a class="elsevierStyleCrossRef" href="#bib0375"><span class="elsevierStyleSup">75</span></a></p><elsevierMultimedia ident="fig0020"></elsevierMultimedia></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Treatment for fragile X syndrome</span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Non-pharmacological treatment</span><p id="par0135" class="elsevierStylePara elsevierViewall">A study in animal models of FXS has shown that exposure to an enriched environment may alleviate behavioural disorders&#59; in this study&#44; changes were assessed using nesting material&#44; physical exercise&#44; and a wide range of plastic toys of different colours and textures&#46;<a class="elsevierStyleCrossRef" href="#bib0380"><span class="elsevierStyleSup">76</span></a> Patients with FXS have been found to benefit from occupational and speech therapy&#46;<a class="elsevierStyleCrossRef" href="#bib0385"><span class="elsevierStyleSup">77</span></a> As a general rule&#44; implementing specific techniques in education centres and the family setting leads to significant improvements in behaviour and autistic symptoms in children with FXS&#46;<a class="elsevierStyleCrossRef" href="#bib0155"><span class="elsevierStyleSup">31</span></a></p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Pharmacological treatment</span><p id="par0140" class="elsevierStylePara elsevierViewall">There are 2 types of pharmacological treatment for FXS&#58; treatment for neuropsychiatric symptoms and treatment focused on the pathophysiology underlying the disease&#46;</p><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Treatment of clinical manifestations</span><p id="par0145" class="elsevierStylePara elsevierViewall">This type of treatment focuses on symptoms and disorders associated with FXS&#44; including ADHD&#44; anxiety&#44; behaviour disorders&#44; and seizures&#46; The most widely used drugs are psychostimulants &#40;for attention deficit and hyperactivity&#41;&#44; serotonin reuptake inhibitors &#40;aggressiveness associated with anxiety&#41;&#44; and atypical antipsychotics &#40;irritability&#41;&#46;<a class="elsevierStyleCrossRefs" href="#bib0390"><span class="elsevierStyleSup">78&#44;79</span></a> Such &#945;-adrenergic receptor agonists as clonidine and guanfacine are preferred for treating ADHD in children younger than 5&#46;<a class="elsevierStyleCrossRef" href="#bib0395"><span class="elsevierStyleSup">79</span></a><span class="elsevierStyleSmallCaps">l</span>-Acetylcarnitine has been found to improve ADHD symptoms in controlled pilot studies&#46;<a class="elsevierStyleCrossRef" href="#bib0400"><span class="elsevierStyleSup">80</span></a> Trials of sertraline in small groups have shown decreased anxiety&#44;<a class="elsevierStyleCrossRef" href="#bib0405"><span class="elsevierStyleSup">81</span></a> and a study of aripiprazole including 15 patients reported significant improvements in irritability&#46;<a class="elsevierStyleCrossRef" href="#bib0390"><span class="elsevierStyleSup">78</span></a> However&#44; randomised double-blind trials with larger numbers of patients should be conducted to validate these treatments&#46;</p><p id="par0150" class="elsevierStylePara elsevierViewall">For patients with seizures&#44; carbamazepine and valproic acid are the current treatments of choice since they are able to control epilepsy and cause few adverse effects&#46;<a class="elsevierStyleCrossRefs" href="#bib0085"><span class="elsevierStyleSup">17&#44;82</span></a> Both lamotrigine and levetiracetam have proven to be effective additions to anticonvulsant treatment in refractory cases&#44; while causing minimal cognitive adverse effects&#46;<a class="elsevierStyleCrossRef" href="#bib0395"><span class="elsevierStyleSup">79</span></a> Phenytoin&#44; phenobarbital&#44; and gabapentin are usually avoided since they either cause adverse effects or exacerbate behavioural disorders&#46;<a class="elsevierStyleCrossRef" href="#bib0395"><span class="elsevierStyleSup">79</span></a></p></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Experimental treatments based on the pathophysiology of fragile X syndrome</span><p id="par0155" class="elsevierStylePara elsevierViewall">Advances in our knowledge of the neurobiology of FXS have led to the development of a range of drugs which act on the neurotransmitter pathways involved in this disease&#46; As with the pathophysiological mechanisms described in <a class="elsevierStyleCrossRef" href="#fig0015">Fig&#46; 3</a>&#44; experimental pharmacological treatments can be classified into those acting on the receptors of the neurotransmitters involved in FXS&#44; those acting on intracellular signalling proteins downstream of neurotransmitters&#44; or those acting on synaptic effector proteins&#46;</p><p id="par0160" class="elsevierStylePara elsevierViewall">The first group includes GABA receptor agonists and different glutamatergic agonists&#44; which compensate overactivation of the glutamatergic pathway caused by FMRP deficits &#40;<a class="elsevierStyleCrossRef" href="#fig0015">Fig&#46; 3</a>&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">48</span></a> This explains how GABA<span class="elsevierStyleInf">A</span> receptor agonists such as ganaxolon control seizures and anxiety in patients with FXS&#44;<a class="elsevierStyleCrossRef" href="#bib0415"><span class="elsevierStyleSup">83</span></a> although they can also cause drowsiness&#46;<a class="elsevierStyleCrossRefs" href="#bib0420"><span class="elsevierStyleSup">84&#44;85</span></a> Baclofen&#44; a GABA<span class="elsevierStyleInf">B</span> receptor agonist&#44; has been shown to be effective for treating hyperactivity and seizures in <span class="elsevierStyleItalic">FMR1</span> knockout mice&#46;<a class="elsevierStyleCrossRef" href="#bib0430"><span class="elsevierStyleSup">86</span></a> Arbaclofen&#44; an isomer of baclofen that is significantly more potent than regular baclofen as a GABA agent&#44; has been shown to decrease irritability and improve social interaction in humans&#44;<a class="elsevierStyleCrossRefs" href="#bib0435"><span class="elsevierStyleSup">87&#44;88</span></a> although further studies should evaluate its toxicity and long-term effects&#46; According to several studies&#44; fenobam&#44; an antagonist of metabotropic glutamate 5 receptor &#40;mGluR5&#41;&#44; effectively improves some behavioural symptoms and reduces dendritic anomalies in the hippocampus of <span class="elsevierStyleItalic">FMR1</span> knockout mice&#46;<a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">48</span></a> A preliminary study including 12 adult patients with FXS treated with a single dose of fenobam showed significant improvements in social interaction and hyperactivity&#59; however&#44; some patients experienced mild sedation and greater anxiety&#46;<a class="elsevierStyleCrossRef" href="#bib0445"><span class="elsevierStyleSup">89</span></a> Several clinical trials of other mGluR5 antagonists are currently underway&#46;<a class="elsevierStyleCrossRef" href="#bib0450"><span class="elsevierStyleSup">90</span></a> Regarding the endocannabinoid system&#44; rimonabant is being tested on animals&#59; this cannabinoid CB1 receptor antagonist prevents interaction between CB1 receptor and its endogenous ligand&#44; 2-arachidonoylglycerol &#40;2-AG&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">48</span></a> Short-term treatment with rimonabant in <span class="elsevierStyleItalic">FMR1</span> knockout mice has been found to completely or partially normalise object-recognition memory and susceptibility to audiogenic seizures&#44; whereas long-term treatment improved dendritic spine density and decreased mTOR signalling in the hippocampus&#46;<a class="elsevierStyleCrossRef" href="#bib0295"><span class="elsevierStyleSup">59</span></a></p><p id="par0165" class="elsevierStylePara elsevierViewall">Several pharmacological treatments which inhibit the proteins involved in intracellular signalling downstream of mGluR are currently being developed &#40;<a class="elsevierStyleCrossRef" href="#fig0015">Fig&#46; 3</a>&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">48</span></a> Glycogen synthase kinase-3 &#40;GSK-3&#41; is overactive in <span class="elsevierStyleItalic">FMR1</span> knockout mice&#46;<a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">48</span></a> Lithium&#44; a GSK-3 inhibitor&#44; is usually well tolerated and has been shown to significantly improve behaviour&#44; adaptive skills&#44; and verbal memory in a pilot study including 15 young patients with FXS&#46;<a class="elsevierStyleCrossRef" href="#bib0455"><span class="elsevierStyleSup">91</span></a> Lovastatin and temsirolimus &#40;ERK and mTOR inhibitors&#44; respectively&#41; reduced memory deficits&#44; susceptibility to audiogenic seizures&#44; and the synthesis of proteins involved in LTD in <span class="elsevierStyleItalic">FMR1</span> knockout mice&#46;<a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">48</span></a></p><p id="par0170" class="elsevierStylePara elsevierViewall">Lastly&#44; inhibitors of synaptic effector proteins are also being explored&#46;<a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">48</span></a> The inhibitory activity of minocycline on MMP-9 has been found to significantly improve intellectual function and decrease anxiety in mice by promoting dendritic spine maturation in the hippocampus&#46;<a class="elsevierStyleCrossRef" href="#bib0460"><span class="elsevierStyleSup">92</span></a> In one preliminary study in humans&#44; minocycline was well tolerated and decreased irritability&#44; stereotypy&#44; hyperactivity&#44; and inappropriate speech&#44; but controlled trials have yet to be performed&#46;<a class="elsevierStyleCrossRef" href="#bib0465"><span class="elsevierStyleSup">93</span></a></p><p id="par0175" class="elsevierStylePara elsevierViewall">No systematic reviews on these pharmacological treatments have been conducted to date due to low patient numbers&#44; short treatment duration&#44; and the difficulties in comparing results from different assessment tools&#46; Although current treatment strategies have an effect on symptoms&#44; they do not improve the cognitive profile of these patients&#46; As a general rule&#44; combination therapy &#40;pharmacological and non-pharmacological treatment&#41; provides greater benefits&#46;<a class="elsevierStyleCrossRef" href="#bib0470"><span class="elsevierStyleSup">94</span></a></p></span></span></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Treatment for fragile X-associated primary ovarian insufficiency and fragile X-associated tremor&#47;ataxia syndrome</span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Treatment for fragile X-associated primary ovarian insufficiency</span><p id="par0180" class="elsevierStylePara elsevierViewall">Women with PM and FXPOI may exhibit symptoms of menopause in addition to the psychological effect of premature loss of their reproductive ability&#46; Even when no specific treatments are available&#44; psychotherapy may be beneficial for patients with FXPOI&#46;<a class="elsevierStyleCrossRef" href="#bib0475"><span class="elsevierStyleSup">95</span></a> We should stress&#44; however&#44; that FXPOI does not rule out the possibility of pregnancy&#59; the reproductive potential of women with this syndrome should therefore be evaluated by a gynaecologist&#46; Likewise&#44; due to these patients&#8217; low serum levels of estradiol and its associated multisystemic consequences&#44; the possibility of hormone replacement therapy should be evaluated by an endocrinologist&#46;<a class="elsevierStyleCrossRef" href="#bib0195"><span class="elsevierStyleSup">39</span></a></p></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Treatment for fragile X-associated tremor&#47;ataxia syndrome</span><p id="par0185" class="elsevierStylePara elsevierViewall">Pharmacological treatment of psychiatric disorders associated with PM is non-specific and includes conventional psychoactive drugs&#46; Selective serotonin reuptake inhibitors are the most widely used medications for mood disorders&#46;<a class="elsevierStyleCrossRef" href="#bib0475"><span class="elsevierStyleSup">95</span></a></p><p id="par0190" class="elsevierStylePara elsevierViewall">No specific treatments have been developed for FXTAS&#44; although some drugs may partially improve symptoms&#46; Propranolol and primidone are the most frequently used drugs for intention tremor&#46; Some studies have reported improvements in patients treated with botulinum toxin&#44; levetiracetam&#44; clonazepam&#44; clozapine&#44; nadolol&#44; and nimodipine&#46;<a class="elsevierStyleCrossRef" href="#bib0215"><span class="elsevierStyleSup">43</span></a> Physical therapy&#44; amantadine&#44; and buspirone have been shown to be beneficial for treating ataxia&#46;<a class="elsevierStyleCrossRef" href="#bib0480"><span class="elsevierStyleSup">96</span></a> Antipsychotics should be used with caution as they may aggravate movement disorders&#46; Quetiapine is associated with a lower risk of extrapyramidal side effects&#46;<a class="elsevierStyleCrossRefs" href="#bib0215"><span class="elsevierStyleSup">43&#44;95</span></a></p><p id="par0195" class="elsevierStylePara elsevierViewall">Although no formal recommendations have been established&#44; PM carriers should undergo analyses of serum levels of thyroid stimulating hormone&#44; free thyroxine&#44; and triiodothyronine at least once a year to detect and treat hypothyroidism as early as possible&#46;<a class="elsevierStyleCrossRef" href="#bib0485"><span class="elsevierStyleSup">97</span></a></p><p id="par0200" class="elsevierStylePara elsevierViewall">Evidence is insufficient to support the use of dementia drugs in patients with FXTAS&#46; However&#44; a recent study showed that administering memantine for a year significantly improved verbal memory in patients with FXTAS&#44;<a class="elsevierStyleCrossRef" href="#bib0490"><span class="elsevierStyleSup">98</span></a> laying the foundation for further clinical trials of this drug&#46;</p><p id="par0205" class="elsevierStylePara elsevierViewall">To date&#44; there have been no experimental studies in which interfering RNA was able to counteract the high levels of mRNA in <span class="elsevierStyleItalic">FMR1</span> in patients with PM&#46; However&#44; RNA intereference constitutes a potential therapeutic target based on experience with oligonucleotides in myotonic dystrophy type 1&#46;<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">37</span></a></p></span></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Genetic counselling</span><p id="par0210" class="elsevierStylePara elsevierViewall">When FXS is suspected&#44; the family must be informed of the possible implications of conducting a genetic study&#44; not only for the patient but also for other family members&#46; Doctors must also stress the importance of referring the patient to a clinical geneticist&#46;<a class="elsevierStyleCrossRef" href="#bib0210"><span class="elsevierStyleSup">42</span></a> A geneticist will assist in family planning by compiling the family&#39;s medical history and making it available to them while providing timely information about the risks of bearing a mutation&#46;<a class="elsevierStyleCrossRefs" href="#bib0210"><span class="elsevierStyleSup">42&#44;99</span></a></p><p id="par0215" class="elsevierStylePara elsevierViewall">The risk of transmitting the mutation to offspring depends on the bearer&#39;s sex and the number of repeats&#46; Male PM carriers will transmit the mutation to all daughters but not to their sons&#46; Female PM carriers have a 50&#37; chance of transmitting the mutated allele in the PM or FM range to any of their offspring&#46; The children of women with FM have a 50&#37; risk of inheriting the FM&#46; The sons of men with FM do not inherit the mutation whereas their daughters may inherit the FM or a PM due to contraction in the CGG repeat number &#40;<a class="elsevierStyleCrossRef" href="#tbl0015">Table 3</a>&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0495"><span class="elsevierStyleSup">99</span></a></p><elsevierMultimedia ident="tbl0015"></elsevierMultimedia><p id="par0220" class="elsevierStylePara elsevierViewall">All family members at risk of carrying PM or FM must be screened for neurological&#44; emotional&#44; and endocrine disorders&#46; Families with mutation carriers may join a support group&#44; especially those for parents of children with fragile X disorders&#44; which are now active in many countries&#46; It is also necessary to gather data about the number of AGG interruptions in PM female carriers in the Latin American population to determine how these interruptions have affected the probability of expansions in the offspring&#46; This is recommended by the clinical guidelines for diagnosis and treatment of <span class="elsevierStyleItalic">FMR1</span>-associated diseases recently published in Spain and based on evidence from the population of the United States&#46;<a class="elsevierStyleCrossRefs" href="#bib0200"><span class="elsevierStyleSup">40&#44;100</span></a></p><p id="par0225" class="elsevierStylePara elsevierViewall">The population with FXS has been studied from many different perspectives&#44; including prenatal diagnosis&#44; disease detection in populations with neurological disorders&#44; and newborn screening&#46;<a class="elsevierStyleCrossRef" href="#bib0505"><span class="elsevierStyleSup">101</span></a> Although the subject is controversial&#44; early diagnosis with newborn screening will permit early treatment&#44; family counselling&#44; and informed decision making&#46;<a class="elsevierStyleCrossRef" href="#bib0510"><span class="elsevierStyleSup">102</span></a> This may result in fewer new cases of FXS when carriers are diagnosed before a second child with the disease is born &#40;<a class="elsevierStyleCrossRef" href="#fig0005">Fig&#46; 1</a>&#41;&#46;</p></span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0120">Conclusions</span><p id="par0230" class="elsevierStylePara elsevierViewall">FXS is associated with a wide range of clinical manifestations&#44; from the classical phenotype of FM carriers to the neurological and psychiatric symptoms linked to the PM&#46;<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">37</span></a> Given this wide range of presentations and the high frequency of the disease&#44; there is a high probability of coming across a patient with FXS at some point during our clinical careers&#46; A molecular study of <span class="elsevierStyleItalic">FMR1</span> must be considered in patients with psychomotor retardation&#44; ID&#44; autism&#44; premature menopause&#44; ataxic gait or intention tremor&#44; parkinsonism&#44; peripheral neuropathy&#44; dementia&#44; anxiety&#44; or depression&#44; especially when there is a family history of ID and&#47;or autism&#46;<a class="elsevierStyleCrossRefs" href="#bib0495"><span class="elsevierStyleSup">99&#44;103</span></a></p><p id="par0235" class="elsevierStylePara elsevierViewall">Psychiatric symptoms in PM carriers may be a primary manifestation of the PM and should therefore not be attributed solely to the stress generated by caring for a child with a disability &#40;although this factor is always present&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0195"><span class="elsevierStyleSup">39</span></a></p><p id="par0240" class="elsevierStylePara elsevierViewall">Molecular studies and genetic counselling &#40;including extended genealogies&#41; are essential for identifying family members with an <span class="elsevierStyleItalic">FMR1</span> mutation and determining individual prognosis and risk of transmitting the disease to offspring&#46;<a class="elsevierStyleCrossRef" href="#bib0495"><span class="elsevierStyleSup">99</span></a></p><p id="par0245" class="elsevierStylePara elsevierViewall">Advances in our understanding of the molecular basis of SXF may help clarify the aetiology of neuropsychiatric disorders and ascertain the mechanisms of neurological and psychiatric symptoms of other genetic diseases&#46; This is likely to lead to increasingly specific treatments&#46;<a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">48</span></a></p></span><span id="sec0075" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0125">Conflicts of interest</span><p id="par0250" class="elsevierStylePara elsevierViewall">The authors have no conflicts of interest to declare&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:14 [
        0 => array:3 [
          "identificador" => "xres829725"
          "titulo" => "Abstract"
          "secciones" => array:3 [
            0 => array:2 [
              "identificador" => "abst0005"
              "titulo" => "Background"
            ]
            1 => array:2 [
              "identificador" => "abst0010"
              "titulo" => "Development"
            ]
            2 => array:2 [
              "identificador" => "abst0015"
              "titulo" => "Conclusions"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec825783"
          "titulo" => "Keywords"
        ]
        2 => array:3 [
          "identificador" => "xres829726"
          "titulo" => "Resumen"
          "secciones" => array:3 [
            0 => array:2 [
              "identificador" => "abst0020"
              "titulo" => "Introducci&#243;n"
            ]
            1 => array:2 [
              "identificador" => "abst0025"
              "titulo" => "Desarrollo"
            ]
            2 => array:2 [
              "identificador" => "abst0030"
              "titulo" => "Conclusiones"
            ]
          ]
        ]
        3 => array:2 [
          "identificador" => "xpalclavsec825782"
          "titulo" => "Palabras clave"
        ]
        4 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Introduction"
        ]
        5 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "Mutations in the fragile X mental retardation 1 gene and associated disorders"
        ]
        6 => array:2 [
          "identificador" => "sec0015"
          "titulo" => "Neurobiology"
        ]
        7 => array:2 [
          "identificador" => "sec0020"
          "titulo" => "Confirmation of diagnosis"
        ]
        8 => array:3 [
          "identificador" => "sec0025"
          "titulo" => "Treatment for fragile X syndrome"
          "secciones" => array:2 [
            0 => array:2 [
              "identificador" => "sec0030"
              "titulo" => "Non-pharmacological treatment"
            ]
            1 => array:3 [
              "identificador" => "sec0035"
              "titulo" => "Pharmacological treatment"
              "secciones" => array:2 [
                0 => array:2 [
                  "identificador" => "sec0040"
                  "titulo" => "Treatment of clinical manifestations"
                ]
                1 => array:2 [
                  "identificador" => "sec0045"
                  "titulo" => "Experimental treatments based on the pathophysiology of fragile X syndrome"
                ]
              ]
            ]
          ]
        ]
        9 => array:3 [
          "identificador" => "sec0050"
          "titulo" => "Treatment for fragile X-associated primary ovarian insufficiency and fragile X-associated tremor&#47;ataxia syndrome"
          "secciones" => array:2 [
            0 => array:2 [
              "identificador" => "sec0055"
              "titulo" => "Treatment for fragile X-associated primary ovarian insufficiency"
            ]
            1 => array:2 [
              "identificador" => "sec0060"
              "titulo" => "Treatment for fragile X-associated tremor&#47;ataxia syndrome"
            ]
          ]
        ]
        10 => array:2 [
          "identificador" => "sec0065"
          "titulo" => "Genetic counselling"
        ]
        11 => array:2 [
          "identificador" => "sec0070"
          "titulo" => "Conclusions"
        ]
        12 => array:2 [
          "identificador" => "sec0075"
          "titulo" => "Conflicts of interest"
        ]
        13 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2014-05-07"
    "fechaAceptado" => "2014-10-23"
    "PalabrasClave" => array:2 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec825783"
          "palabras" => array:5 [
            0 => "Intellectual disability"
            1 => "Fagile X mental retardation protein"
            2 => "Autism spectrum disorders"
            3 => "Ribonucleic acid-binding proteins"
            4 => "Deoxyribonucleic acid methylation"
          ]
        ]
      ]
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec825782"
          "palabras" => array:5 [
            0 => "Discapacidad intelectual"
            1 => "Prote&#237;na FMRP"
            2 => "Trastornos del espectro autista"
            3 => "Prote&#237;nas de uni&#243;n al RNA"
            4 => "Metilaci&#243;n del ADN"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:3 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Background</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Fragile <span class="elsevierStyleSmallCaps">X</span> syndrome&#44; the most common inherited cause of intellectual disability&#44; is associated with a broad spectrum of disorders across different generations of a single family&#46; This study reviews the clinical manifestations of fragile <span class="elsevierStyleSmallCaps">X</span>-associated disorders as well as the spectrum of mutations of the fragile <span class="elsevierStyleSmallCaps">X</span> mental retardation 1 gene &#40;<span class="elsevierStyleItalic">FMR1</span>&#41; and the neurobiology of the fragile <span class="elsevierStyleSmallCaps">X</span> mental retardation protein &#40;FMRP&#41;&#44; and also provides an overview of the potential therapeutic targets and genetic counselling&#46;</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Development</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">This disorder is caused by expansion of the CGG repeat &#40;&#62;200 repeats&#41; in the 5 prime untranslated region of <span class="elsevierStyleItalic">FMR1</span>&#44; resulting in a deficit or absence of FMRP&#46; FMRP is an RNA-binding protein that regulates the translation of several genes that are important in synaptic plasticity and dendritic maturation&#46; It is believed that CGG repeat expansions in the premutation range &#40;55&#8211;200 repeats&#41; elicit an increase in mRNA levels of <span class="elsevierStyleItalic">FMR1</span>&#44; which may cause neuronal toxicity&#46; These changes manifest clinically as developmental problems such as autism and learning disabilities as well as neurodegenerative diseases including fragile <span class="elsevierStyleSmallCaps">X</span>-associated tremor&#47;ataxia syndrome &#40;FXTAS&#41;&#46;</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Conclusions</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Advances in identifying the molecular basis of fragile <span class="elsevierStyleSmallCaps">X</span> syndrome may help us understand the causes of neuropsychiatric disorders&#44; and they will probably contribute to development of new and specific treatments&#46;</p></span>"
        "secciones" => array:3 [
          0 => array:2 [
            "identificador" => "abst0005"
            "titulo" => "Background"
          ]
          1 => array:2 [
            "identificador" => "abst0010"
            "titulo" => "Development"
          ]
          2 => array:2 [
            "identificador" => "abst0015"
            "titulo" => "Conclusions"
          ]
        ]
      ]
      "es" => array:3 [
        "titulo" => "Resumen"
        "resumen" => "<span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Introducci&#243;n</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">El s&#237;ndrome X fr&#225;gil &#40;SXF&#41; es la causa m&#225;s frecuente de discapacidad intelectual hereditaria y se asocia a un amplio espectro de enfermedades en las distintas generaciones de una misma familia&#46; En este trabajo se revisan las manifestaciones cl&#237;nicas de los trastornos asociados al X fr&#225;gil y el espectro de mutaciones en el gen 1 del retraso mental del X fr&#225;gil <span class="elsevierStyleItalic">&#40;FMR1&#41;</span>&#44; la neurobiolog&#237;a de la prote&#237;na del retardo mental X fr&#225;gil &#40;FMRP&#41; y una visi&#243;n general de los potenciales blancos terap&#233;uticos y el asesoramiento gen&#233;tico&#46;</p></span> <span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Desarrollo</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Esta enfermedad es causada por una amplificaci&#243;n de las repeticiones CGG &#40;&#62;<span class="elsevierStyleHsp" style=""></span>200 repeticiones&#41; en la regi&#243;n 5&#8217; no traducida del gen <span class="elsevierStyleItalic">FMR1</span>&#44; que lleva al d&#233;ficit o ausencia de la prote&#237;na FMRP&#46; La FMRP es una prote&#237;na de uni&#243;n al ARN que regula la traducci&#243;n de varios genes que son importantes en la plasticidad sin&#225;ptica y la maduraci&#243;n dendr&#237;tica&#46; Se cree que expansiones de las repeticiones CGG en el rango de premutaci&#243;n &#40;55-200 repeticiones&#41; generan un aumento en los niveles de mRNA de <span class="elsevierStyleItalic">FMR1</span>&#44; lo que producir&#237;a toxicidad neuronal&#46; Esto se manifiesta en problemas del desarrollo tales como autismo y problemas de aprendizaje&#44; as&#237; como en patolog&#237;as neurodegenerativas como el s&#237;ndrome de temblor&#47;ataxia asociado al X fr&#225;gil &#40;FXTAS&#41;&#46;</p></span> <span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Conclusiones</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Los avances en la identificaci&#243;n de las bases moleculares del SXF pueden servir como modelo para comprender las causas de las enfermedades neuropsiqui&#225;tricas y probablemente conducir&#225;n al desarrollo de tratamientos cada vez m&#225;s espec&#237;ficos&#46;</p></span>"
        "secciones" => array:3 [
          0 => array:2 [
            "identificador" => "abst0020"
            "titulo" => "Introducci&#243;n"
          ]
          1 => array:2 [
            "identificador" => "abst0025"
            "titulo" => "Desarrollo"
          ]
          2 => array:2 [
            "identificador" => "abst0030"
            "titulo" => "Conclusiones"
          ]
        ]
      ]
    ]
    "NotaPie" => array:2 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0025">Please cite this article as&#58; Pugin A&#44; Faundes V&#44; Santa Mar&#237;a L&#44; Curotto B&#44; Aliaga S&#44; Salas I&#44; et al&#46; Aspectos cl&#237;nicos&#44; moleculares y farmacol&#243;gicos en los trastornos asociados a gen 1 del retraso mental del X fr&#225;gil&#46; Neurolog&#237;a&#46; 2017&#59;32&#58;241&#8211;252&#46;</p>"
      ]
      1 => array:3 [
        "etiqueta" => "1"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0030">These authors contributed equally to this work&#46;</p>"
        "identificador" => "fn0005"
      ]
    ]
    "multimedia" => array:7 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figure 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 887
            "Ancho" => 2334
            "Tamanyo" => 142832
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Family photo and genealogy showing the spectrum of fragile X-associated disorders&#46; &#40;A&#41; Members I&#46;2 and II&#46;2 had PMs of 83 and 96 CGG triplets and manifested premature ovarian insufficiency at the ages of 35 and 36&#44; respectively&#46; Members III&#46;2 and III&#46;3 had FMs of 370 and 570 CGG triplets and were diagnosed with FXS at the ages of 5 and 1&#44; respectively&#46; &#40;B&#41; Photo of some members of the family indicating their positions in the genealogy&#46;</p>"
        ]
      ]
      1 => array:7 [
        "identificador" => "fig0010"
        "etiqueta" => "Figure 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 1211
            "Ancho" => 3002
            "Tamanyo" => 195677
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Genomic location and role of <span class="elsevierStyleItalic">FMR1</span> and <span class="elsevierStyleItalic">FMR1-AS1</span>&#46; The grey bar represents the genomic position &#40;in kilobases &#91;kb&#93;&#41; of both genes on the X chromosome from the P-terminal end&#46; The black square represents the CpG island involved in silencing both genes in patients with FM&#46; The arrows placed next to the CpG island and each gene represent the direction of transcription&#46; The vertical lines in <span class="elsevierStyleItalic">FMR1</span> represent the exons of this gene&#46;</p>"
        ]
      ]
      2 => array:7 [
        "identificador" => "fig0015"
        "etiqueta" => "Figure 3"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr3.jpeg"
            "Alto" => 2085
            "Ancho" => 2669
            "Tamanyo" => 353658
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Diagram of the neurobiology of FMRP and the different therapeutic targets and drugs used for FXS according to the cellular components with which that protein interacts&#46; Ganaxolone and arbaclofen are GABA<span class="elsevierStyleInf">A</span> and GABA<span class="elsevierStyleInf">B</span> receptor agonists&#44; respectively&#59; fenobam is an mGluR5 antagonist&#59; and rimonabant is a cannabinoid CB1 receptor antagonist&#46; Targets in signal transduction pathways are GSK3&#44; ERK&#44; and mTOR&#44; which are inhibited by lithium&#44; lovastatin&#44; and temsirolimus&#44; respectively&#46; Lastly&#44; minocycline inhibits the matrix metalloproteinase MMP-9&#46;</p>"
        ]
      ]
      3 => array:7 [
        "identificador" => "fig0020"
        "etiqueta" => "Figure 4"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr4.jpeg"
            "Alto" => 566
            "Ancho" => 1500
            "Tamanyo" => 80384
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Molecular results in the diagnosis of <span class="elsevierStyleItalic">FMR1</span>-related disorders&#46; &#40;A&#41; Southern blot results&#46; Lanes 1 and 7&#58; female non-carrier&#59; lane 2&#58; female FM carrier&#59; lane 9&#58; female PM carrier&#59; lane 4&#58; male non-carrier&#59; lane 3&#58; male FM carrier&#59; lanes 5 and 8&#58; male mosaic &#40;PM&#47;FM&#41; carriers&#59; lane 6&#58; partially demethylated male FM carrier&#46; &#40;B&#41; Diagnostic results from PCR&#46; Lanes 1 and 2&#58; male PM carriers&#59; lanes 3&#44; 6&#44; and 9&#58; male non-carriers&#59; lane 4&#58; female non-carrier &#40;homozygosity confirmed by Southern blot&#41;&#59; lane 5&#58; female PM carrier&#59; lane 7&#58; female mosaic &#40;PM&#47;FM&#41; carrier&#59; lane 8&#58; male FM carrier&#59; lane 10&#58; female non-carrier &#40;heterozygous&#41;&#46; St&#58; molecular weight standard of 100<span class="elsevierStyleHsp" style=""></span>bp &#40;Invitrogen&#41;&#46; White bar&#58; normal range &#40;&#60; 55 CGG repeats&#41;&#46; Grey bar&#58; PM range &#40;55&#8211;200 CGG repeats&#41;&#46; Black bar&#58; FM range &#40;&#62; 200 CGG repeats&#41;&#46;</p>"
        ]
      ]
      4 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Table 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Major diagnostic criteria&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Minor diagnostic criteria&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="" valign="top" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Molecular</span><br><span class="elsevierStyleHsp" style=""></span>55&#8211;200 repeats<br><br><span class="elsevierStyleItalic">Radiological</span><a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a><br><span class="elsevierStyleHsp" style=""></span>T2-weighted hyperintense white matter lesions in the middle cerebellar peduncles<br><br><span class="elsevierStyleItalic">Clinical</span><br><span class="elsevierStyleHsp" style=""></span>Intention tremor<br><span class="elsevierStyleHsp" style=""></span>Ataxic gait<br><br><span class="elsevierStyleItalic">Neuropathological</span><br><span class="elsevierStyleHsp" style=""></span>FXTAS inclusions&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic">Radiological</span><a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a><br><span class="elsevierStyleHsp" style=""></span>T2-weighted hyperintense cerebral white matter lesions<br><span class="elsevierStyleHsp" style=""></span>Moderate to severe generalised atrophy<br><br><span class="elsevierStyleItalic">Clinical</span><br><span class="elsevierStyleHsp" style=""></span>Parkinsonism<br><span class="elsevierStyleHsp" style=""></span>Moderate to severe short-term memory impairment<br><span class="elsevierStyleHsp" style=""></span>Executive function deficits&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="3" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="3" align="left" valign="top"><span class="elsevierStyleBold">Diagnostic categories &#40;patient must also meet the molecular requirement&#41;</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Definitive</span><br><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Presence of a major radiological sign plus &#40;a&#41; a major clinical sign&#44; or &#40;b&#41; FXTAS inclusions&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic">Probable</span><br>Presence of &#40;a&#41; a major radiological sign and a minor clinical sign or &#40;b&#41; 2 major clinical signs&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic">Possible</span><br>Presence of a minor radiological sign plus a major clinical sign&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1396160.png"
              ]
            ]
          ]
          "notaPie" => array:2 [
            0 => array:3 [
              "identificador" => "tblfn0005"
              "etiqueta" => "a"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Adapted from Hagerman and Hagerman&#46;<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">37</span></a></p>"
            ]
            1 => array:3 [
              "identificador" => "tblfn0010"
              "etiqueta" => "b"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0010">MRI&#46;</p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Diagnostic criteria and diagnostic categories for FXTAS&#46;<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a></p>"
        ]
      ]
      5 => array:8 [
        "identificador" => "tbl0010"
        "etiqueta" => "Table 2"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at2"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td-with-role" title="table-head ; entry_with_role_rowhead " align="left" valign="top" scope="col">Type of mutation&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col">Number of CGG repeats&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col">Methylation status of <span class="elsevierStyleItalic">FMR1</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " colspan="2" align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Clinical manifestations</th></tr><tr title="table-row"><th class="td" title="table-head  " align="" valign="top" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="" valign="top" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="" valign="top" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Men&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Women&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Grey-zone&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">45&#8211;54&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Unmethylated&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Risk of FXTAS&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Risk of FXTAS and FXPOI&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Premutation&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">55&#8211;200&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Unmethylated&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Risk of FXTAS&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Risk of FXTAS and FXPOI&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Full mutation&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">&#62;200&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Completely methylated&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">100&#37; with intellectual disability &#40;ID&#41; and classic physical features&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">&#8764;50&#37; with ID and classic physical features&#44; though milder&#59; &#8764;50&#37; with normal intellectual capacity&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Size mosaicism&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">PM or FM&#44; depending on the cell line&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Partial&#58; demethylated in PM cells and methylated in FM cells&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " rowspan="2" align="left" valign="middle">&#8764;100&#37; with ID although higher functioning than male FM carriers&#46; Physical features are usually milder</td><td class="td" title="table-entry  " rowspan="3" align="left" valign="middle">Highly variable&#44; from normal intellectual capacity to ID associated with mild physical features</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Methylation mosaicism&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">&#62;200&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Partial&#58; methylated and unmethylated cell lines&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Unmethylated full mutation&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">&#62;200&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Unmethylated&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Cognitive abilities range from mild ID to lower-end normal intellectual functioning&#59; mild physical features&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1396159.png"
              ]
            ]
          ]
          "notaPie" => array:1 [
            0 => array:3 [
              "identificador" => "tblfn0015"
              "etiqueta" => "a"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0015">Adapted from GeneReviews&#46;<a class="elsevierStyleCrossRef" href="#bib0195"><span class="elsevierStyleSup">39</span></a></p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Types of <span class="elsevierStyleItalic">FMR1</span> mutations and associated clinical manifestations&#46;<a class="elsevierStyleCrossRef" href="#tblfn0015"><span class="elsevierStyleSup">a</span></a></p>"
        ]
      ]
      6 => array:8 [
        "identificador" => "tbl0015"
        "etiqueta" => "Table 3"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at3"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Parent&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Type of mutation&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Risk of having an affected son&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Risk of having an affected daughter&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Man&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Premutation&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">100&#37; premutation&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Woman&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Premutation&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">50&#37; full mutation or premutation<a class="elsevierStyleCrossRef" href="#tblfn0020"><span class="elsevierStyleSup">a</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">50&#37; full mutation or premutation<a class="elsevierStyleCrossRef" href="#tblfn0020"><span class="elsevierStyleSup">a</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Man&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Full mutation&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">100&#37; full mutation&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Woman&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Full mutation&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">50&#37; full mutation&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">50&#37; full mutation&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1396158.png"
              ]
            ]
          ]
          "notaPie" => array:1 [
            0 => array:3 [
              "identificador" => "tblfn0020"
              "etiqueta" => "a"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0020">The risk of expansion of a premutation into a full mutation depends on the size of the premutation&#46;</p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">Risk of transmitting the mutation to offspring&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:103 [
            0 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The epidemiology of mental retardation&#58; challenges and opportunities in the new millennium"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/mrdd.10031"
                      "Revista" => array:6 [
                        "tituloSerie" => "Ment Retard Dev Disabil Res Rev"
                        "fecha" => "2002"
                        "volumen" => "8"
                        "paginaInicial" => "117"
                        "paginaFinal" => "134"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0010"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The fragile X prevalence paradox"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1136/jmg.2008.059055"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Med Genet"
                        "fecha" => "2008"
                        "volumen" => "45"
                        "paginaInicial" => "498"
                        "paginaFinal" => "499"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0015"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The fragile X family of disorders&#58; a model for autism and targeted treatments"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Curr Pediatr Rev"
                        "fecha" => "2008"
                        "volumen" => "4"
                        "paginaInicial" => "40"
                        "paginaFinal" => "52"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0020"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Prevalence of the fragile X syndrome in African-Americans"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/ajmg.10427"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Med Genet"
                        "fecha" => "2002"
                        "volumen" => "110"
                        "paginaInicial" => "226"
                        "paginaFinal" => "233"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0025"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Prevalence of carriers of premutation-size alleles of the FMRI gene and implications for the population genetics of the fragile X syndrome"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Hum Genet"
                        "fecha" => "1995"
                        "volumen" => "57"
                        "paginaInicial" => "1006"
                        "paginaFinal" => "1018"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Advances in understanding fragile X syndrome and related disorders"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/MOP.0b013e32834c7f1a"
                      "Revista" => array:6 [
                        "tituloSerie" => "Curr Opin Pediatr"
                        "fecha" => "2011"
                        "volumen" => "23"
                        "paginaInicial" => "601"
                        "paginaFinal" => "606"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Physical and behavioral phenotype"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "LibroEditado" => array:6 [
                        "editores" => "R&#46;J&#46;HagermanP&#46;J&#46;Hagerman"
                        "paginaInicial" => "3"
                        "paginaFinal" => "109"
                        "serieVolumen" => "vol&#46; 3"
                        "serieTitulo" => "Fragile X syndrome&#58; diagnosis&#44; treatment and research"
                        "serieFecha" => "2002"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Medical follow-up and pharmacotherapy"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "LibroEditado" => array:6 [
                        "editores" => "R&#46;J&#46;HagermanP&#46;J&#46;Hagerman"
                        "paginaInicial" => "287"
                        "paginaFinal" => "338"
                        "serieVolumen" => "vol&#46; 3"
                        "serieTitulo" => "Fragile X syndrome&#58; diagnosis&#44; treatment and research"
                        "serieFecha" => "2002"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Do young boys with fragile X syndrome have macroorchidism&#63;"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Pediatrics"
                        "fecha" => "1994"
                        "volumen" => "93"
                        "paginaInicial" => "992"
                        "paginaFinal" => "995"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Cognitive&#44; language and social-cognitive skills of individuals with fragile X syndrome with and without autism"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1365-2788.2006.00803.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Intellect Disabil Res"
                        "fecha" => "2006"
                        "volumen" => "50"
                        "paginaInicial" => "532"
                        "paginaFinal" => "545"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Autism spectrum disorder in fragile X syndrome&#58; communication&#44; social interaction&#44; and specific behaviors"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/ajmg.a.30229"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Med Genet"
                        "fecha" => "2004"
                        "volumen" => "129A"
                        "paginaInicial" => "225"
                        "paginaFinal" => "234"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The behavioral phenotype in fragile X&#58; symptoms of autism in very young children with fragile X syndrome&#44; idiopathic autism&#44; and other developmental disorders"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Dev Behav Pediatr"
                        "fecha" => "2001"
                        "volumen" => "22"
                        "paginaInicial" => "409"
                        "paginaFinal" => "417"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Mapping nonverbal IQ in young boys with fragile X syndrome"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Am J Med Genet A"
                        "fecha" => "2005"
                        "volumen" => "132"
                        "paginaInicial" => "25"
                        "paginaFinal" => "32"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Phenotypic variation and FMRP levels in fragile X"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/mrdd.20006"
                      "Revista" => array:7 [
                        "tituloSerie" => "Ment Retard Dev Disabil Res Rev"
                        "fecha" => "2004"
                        "volumen" => "10"
                        "paginaInicial" => "31"
                        "paginaFinal" => "41"
                        "link" => array:1 [ …1]
                        "itemHostRev" => array:3 [ …3]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Academic skills of boys with fragile X syndrome&#58; profiles and predictors"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1352/0895-8017(2005)110<107:ASOBWF>2.0.CO;2"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Ment Retard"
                        "fecha" => "2005"
                        "volumen" => "110"
                        "paginaInicial" => "107"
                        "paginaFinal" => "120"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Fragile X syndrome&#58; assessment and treatment implications"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.chc.2007.03.001"
                      "Revista" => array:7 [
                        "tituloSerie" => "Child Adolesc Psychiatr Clin N Am"
                        "fecha" => "2007"
                        "volumen" => "16"
                        "paginaInicial" => "663"
                        "paginaFinal" => "675"
                        "link" => array:1 [ …1]
                        "itemHostRev" => array:3 [ …3]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "17"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Seizure in fragile X syndrome&#58; characteristics and comorbid diagnoses"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1352/1944-7558-115.6.461"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Intellect Dev Disabil"
                        "fecha" => "2010 Nov"
                        "volumen" => "115"
                        "paginaInicial" => "461"
                        "paginaFinal" => "472"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "18"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Secondary medical diagnosis in fragile X syndrome with and without autism spectrum disorder"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/ajmg.a.32290"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Med Genet A"
                        "fecha" => "2008"
                        "volumen" => "146A"
                        "paginaInicial" => "1911"
                        "paginaFinal" => "1916"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "19"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Autism spectrum disorder in Fragile X syndrome&#58; differential contribution of adaptive socialization and social withdrawal"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/ajmg.a.31405"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Med Genet A"
                        "fecha" => "2006"
                        "volumen" => "140A"
                        "paginaInicial" => "1814"
                        "paginaFinal" => "1826"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            19 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "20"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Co-occurring conditions associated with FMR1 gene variations&#58; findings from a national parent survey"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/ajmg.a.32439"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Med Genet A"
                        "fecha" => "2008"
                        "volumen" => "146A"
                        "paginaInicial" => "2060"
                        "paginaFinal" => "2069"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            20 => array:3 [
              "identificador" => "bib0105"
              "etiqueta" => "21"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Self-injurious behavior and fragile X syndrome&#58; findings from the national fragile X survey"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1352/1944-7558-115.6.473"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Intellect Dev Disabil"
                        "fecha" => "2010"
                        "volumen" => "115"
                        "paginaInicial" => "473"
                        "paginaFinal" => "481"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            21 => array:3 [
              "identificador" => "bib0110"
              "etiqueta" => "22"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The Prader-Willi phenotype of fragile X syndrome"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/01.DBP.0000267563.18952.c9"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Dev Behav Pediatr"
                        "fecha" => "2007"
                        "volumen" => "28"
                        "paginaInicial" => "133"
                        "paginaFinal" => "138"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            22 => array:3 [
              "identificador" => "bib0115"
              "etiqueta" => "23"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Fragile X syndrome&#58; the FMR1 CGG repeat distribution among world populations"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1469-1809.2011.00694.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann Hum Genet"
                        "fecha" => "2012"
                        "volumen" => "76"
                        "paginaInicial" => "178"
                        "paginaFinal" => "191"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            23 => array:3 [
              "identificador" => "bib0120"
              "etiqueta" => "24"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Science"
                        "fecha" => "1991"
                        "volumen" => "252"
                        "paginaInicial" => "1097"
                        "paginaFinal" => "1102"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            24 => array:3 [
              "identificador" => "bib0125"
              "etiqueta" => "25"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Molecular and cellular aspects of mental retardation in the Fragile X syndrome&#58; from gene mutation&#47;s to spine dysmorphogenesis"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/978-3-7091-0932-8_23"
                      "Revista" => array:6 [
                        "tituloSerie" => "Adv Exp Med Biol"
                        "fecha" => "2012"
                        "volumen" => "970"
                        "paginaInicial" => "517"
                        "paginaFinal" => "551"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            25 => array:3 [
              "identificador" => "bib0130"
              "etiqueta" => "26"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Expression of the FMR1 gene"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "72846"
                      "Revista" => array:7 [
                        "tituloSerie" => "Cytogenet Genome Res"
                        "fecha" => "2003"
                        "volumen" => "100"
                        "paginaInicial" => "124"
                        "paginaFinal" => "128"
                        "link" => array:1 [ …1]
                        "itemHostRev" => array:3 [ …3]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            26 => array:3 [
              "identificador" => "bib0135"
              "etiqueta" => "27"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Promoter-bound trinucleotide repeat mRNA drives epigenetic silencing in fragile X syndrome"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1126/science.1245831"
                      "Revista" => array:6 [
                        "tituloSerie" => "Science"
                        "fecha" => "2014"
                        "volumen" => "343"
                        "paginaInicial" => "1002"
                        "paginaFinal" => "1005"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            27 => array:3 [
              "identificador" => "bib0140"
              "etiqueta" => "28"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A point mutation in the FMR-1 gene associated with fragile X mental retardation"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/ng0193-31"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nat Genet"
                        "fecha" => "1993"
                        "volumen" => "3"
                        "paginaInicial" => "31"
                        "paginaFinal" => "35"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            28 => array:3 [
              "identificador" => "bib0145"
              "etiqueta" => "29"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical involvement and protein expression in individuals with the FMR1 premutation"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Med Genet"
                        "fecha" => "2000"
                        "volumen" => "91"
                        "paginaInicial" => "144"
                        "paginaFinal" => "152"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            29 => array:3 [
              "identificador" => "bib0150"
              "etiqueta" => "30"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "FXTAS in an unmethylated mosaic male with fragile X syndrome from Chile"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/cge.12278"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Genet"
                        "fecha" => "2014"
                        "volumen" => "86"
                        "paginaInicial" => "378"
                        "paginaFinal" => "382"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            30 => array:3 [
              "identificador" => "bib0155"
              "etiqueta" => "31"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Genetic and environmental influences on the cognitive outcomes of children with fragile X syndrome"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/00004583-200203000-00002"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Acad Child Adolesc Psychiatry"
                        "fecha" => "2002"
                        "volumen" => "41"
                        "paginaInicial" => "237"
                        "paginaFinal" => "244"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            31 => array:3 [
              "identificador" => "bib0160"
              "etiqueta" => "32"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Mental status of females with an FMR1 gene full mutation"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Hum Genet"
                        "fecha" => "1996"
                        "volumen" => "58"
                        "paginaInicial" => "1025"
                        "paginaFinal" => "1032"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            32 => array:3 [
              "identificador" => "bib0165"
              "etiqueta" => "33"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A neuropsychological investigation of male premutation carriers of fragile X syndrome"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.neuropsychologia.2004.05.002"
                      "Revista" => array:6 [
                        "tituloSerie" => "Neuropsychologia"
                        "fecha" => "2004"
                        "volumen" => "42"
                        "paginaInicial" => "1934"
                        "paginaFinal" => "1947"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            33 => array:3 [
              "identificador" => "bib0170"
              "etiqueta" => "34"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Elevated levels of FMR1 mRNA in carrier males&#58; a new mechanism of involvement in the fragile-X syndrome"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1086/302720"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Hum Genet"
                        "fecha" => "2000"
                        "volumen" => "66"
                        "paginaInicial" => "6"
                        "paginaFinal" => "15"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            34 => array:3 [
              "identificador" => "bib0175"
              "etiqueta" => "35"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Penetrance of the fragile X-associated tremor&#47;ataxia syndrome in a premutation carrier population"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/jama.291.4.460"
                      "Revista" => array:6 [
                        "tituloSerie" => "JAMA"
                        "fecha" => "2004"
                        "volumen" => "291"
                        "paginaInicial" => "460"
                        "paginaFinal" => "469"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            35 => array:3 [
              "identificador" => "bib0180"
              "etiqueta" => "36"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Motor and mental dysfunction in mother&#8211;daughter transmitted FXTAS"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1212/WNL.0b013e3181f73660"
                      "Revista" => array:7 [
                        "tituloSerie" => "Neurology"
                        "fecha" => "2010"
                        "volumen" => "75"
                        "paginaInicial" => "1370"
                        "paginaFinal" => "1376"
                        "link" => array:1 [ …1]
                        "itemHostRev" => array:3 [ …3]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            36 => array:3 [
              "identificador" => "bib0185"
              "etiqueta" => "37"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor&#47;ataxia syndrome"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S1474-4422(13)70125-X"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet Neurol"
                        "fecha" => "2013"
                        "volumen" => "12"
                        "paginaInicial" => "786"
                        "paginaFinal" => "798"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            37 => array:3 [
              "identificador" => "bib0190"
              "etiqueta" => "38"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "FMR1 gene premutation is a frequent genetic cause of late-onset sporadic cerebellar ataxia"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1212/01.WNL.0000148723.37489.3F"
                      "Revista" => array:6 [
                        "tituloSerie" => "Neurology"
                        "fecha" => "2005"
                        "volumen" => "64"
                        "paginaInicial" => "145"
                        "paginaFinal" => "147"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            38 => array:3 [
              "identificador" => "bib0195"
              "etiqueta" => "39"
              "referencia" => array:1 [
                0 => array:3 [
                  "comentario" => "2012 April 26&#46; Available at&#58; <span class="elsevierStyleInterRef" id="intr0010" href="http://www.ncbi.nlm.nih.gov/books/NBK1384/">http&#58;&#47;&#47;www&#46;ncbi&#46;nlm&#46;nih&#46;gov&#47;books&#47;NBK1384&#47;</span> &#91;cited 06&#46;10&#46;14&#93;&#46;"
                  "contribucion" => array:1 [
                    0 => array:1 [
                      "titulo" => "FMR1-related disorders"
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Libro" => array:4 [
                        "titulo" => "GeneReviews &#91;Internet&#93;"
                        "fecha" => "1993&#8211;2014"
                        "editorial" => "University of Washington"
                        "editorialLocalizacion" => "Seattle"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            39 => array:3 [
              "identificador" => "bib0200"
              "etiqueta" => "40"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "AGG interruptions within the maternal FMR1 gene reduce the risk of offspring with fragile X syndrome"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/gim.2012.34"
                      "Revista" => array:6 [
                        "tituloSerie" => "Genet Med"
                        "fecha" => "2012"
                        "volumen" => "14"
                        "paginaInicial" => "729"
                        "paginaFinal" => "736"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            40 => array:3 [
              "identificador" => "bib0205"
              "etiqueta" => "41"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Technical standards and guidelines for fragile X&#58; the first of a series of disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics&#46; Quality Assurance Subcommittee of the Laboratory Practice Committee"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.109700125817-200105000-00010"
                      "Revista" => array:6 [
                        "tituloSerie" => "Genet Med"
                        "fecha" => "2001"
                        "volumen" => "3"
                        "paginaInicial" => "200"
                        "paginaFinal" => "205"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            41 => array:3 [
              "identificador" => "bib0210"
              "etiqueta" => "42"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disorders"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s10897-007-9099-y"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Genet Couns"
                        "fecha" => "2007"
                        "volumen" => "16"
                        "paginaInicial" => "593"
                        "paginaFinal" => "606"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            42 => array:3 [
              "identificador" => "bib0215"
              "etiqueta" => "43"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Treatment of fragile X-associated tremor ataxia syndrome &#40;FXTAS&#41; and related neurological problems"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Interv Aging"
                        "fecha" => "2008"
                        "volumen" => "3"
                        "paginaInicial" => "251"
                        "paginaFinal" => "262"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            43 => array:3 [
              "identificador" => "bib0220"
              "etiqueta" => "44"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Non-coding RNAs as direct and indirect modulators of epigenetic regulation"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.4161/epi.27473"
                      "Revista" => array:6 [
                        "tituloSerie" => "Epigenetics"
                        "fecha" => "2014"
                        "volumen" => "9"
                        "paginaInicial" => "3"
                        "paginaFinal" => "12"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            44 => array:3 [
              "identificador" => "bib0225"
              "etiqueta" => "45"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Long non-coding RNAs in neurodevelopmental disorders"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3389/fnmol.2013.00053"
                      "Revista" => array:5 [
                        "tituloSerie" => "Front Mol Neurosci"
                        "fecha" => "2013"
                        "volumen" => "6"
                        "paginaInicial" => "53"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            45 => array:3 [
              "identificador" => "bib0230"
              "etiqueta" => "46"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The protein product of the fragile X gene&#44; FMR1&#44; has characteristics of an RNA binding protein"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Cell"
                        "fecha" => "1993"
                        "volumen" => "74"
                        "paginaInicial" => "291"
                        "paginaFinal" => "298"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            46 => array:3 [
              "identificador" => "bib0235"
              "etiqueta" => "47"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Distribution of fragile X mental retardation protein in the human auditory brainstem"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.neuroscience.2014.05.006"
                      "Revista" => array:6 [
                        "tituloSerie" => "Neuroscience"
                        "fecha" => "2014"
                        "volumen" => "273"
                        "paginaInicial" => "79"
                        "paginaFinal" => "91"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            47 => array:3 [
              "identificador" => "bib0240"
              "etiqueta" => "48"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Fragile X syndrome neurobiology translates into rational therapy"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.drudis.2014.01.013"
                      "Revista" => array:6 [
                        "tituloSerie" => "Drug Discov Today"
                        "fecha" => "2014"
                        "volumen" => "19"
                        "paginaInicial" => "510"
                        "paginaFinal" => "519"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            48 => array:3 [
              "identificador" => "bib0245"
              "etiqueta" => "49"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Fragile X syndrome from molecular pathology to therapy"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.neubiorev.2014.01.006"
                      "Revista" => array:6 [
                        "tituloSerie" => "Neurosci Biobehav Rev"
                        "fecha" => "2014"
                        "volumen" => "46"
                        "paginaInicial" => "242"
                        "paginaFinal" => "255"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            49 => array:3 [
              "identificador" => "bib0250"
              "etiqueta" => "50"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Fragile X mental retardation protein regulates translation by binding directly to the ribosome"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.molcel.2014.03.023"
                      "Revista" => array:6 [
                        "tituloSerie" => "Mol Cell"
                        "fecha" => "2014"
                        "volumen" => "54"
                        "paginaInicial" => "407"
                        "paginaFinal" => "417"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            50 => array:3 [
              "identificador" => "bib0255"
              "etiqueta" => "51"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Mechanism-based treatments in neurodevelopmental disorders&#58; fragile X syndrome"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.pediatrneurol.2013.12.001"
                      "Revista" => array:7 [
                        "tituloSerie" => "Pediatr Neurol"
                        "fecha" => "2014"
                        "volumen" => "50"
                        "paginaInicial" => "297"
                        "paginaFinal" => "302"
                        "link" => array:1 [ …1]
                        "itemHostRev" => array:3 [ …3]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            51 => array:3 [
              "identificador" => "bib0260"
              "etiqueta" => "52"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The Fragile X mental retardation protein regulates matrix metalloproteinase 9 mRNA at synapses"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1523/JNEUROSCI.2207-13.2013"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Neurosci"
                        "fecha" => "2013"
                        "volumen" => "33"
                        "paginaInicial" => "18234"
                        "paginaFinal" => "18241"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            52 => array:3 [
              "identificador" => "bib0265"
              "etiqueta" => "53"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "GABAergic circuit dysfunction in the Drosophila Fragile X syndrome model"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.nbd.2014.01.008"
                      "Revista" => array:7 [
                        "tituloSerie" => "Neurobiol Dis"
                        "fecha" => "2014"
                        "volumen" => "65"
                        "paginaInicial" => "142"
                        "paginaFinal" => "159"
                        "link" => array:1 [ …1]
                        "itemHostRev" => array:3 [ …3]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            53 => array:3 [
              "identificador" => "bib0270"
              "etiqueta" => "54"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The fragile X syndrome&#58; from molecular genetics to neurobiology"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/mrdd.20010"
                      "Revista" => array:6 [
                        "tituloSerie" => "Ment Retard Dev Disabil Res Rev"
                        "fecha" => "2004"
                        "volumen" => "10"
                        "paginaInicial" => "60"
                        "paginaFinal" => "67"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            54 => array:3 [
              "identificador" => "bib0275"
              "etiqueta" => "55"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A direct role for FMRP in activity-dependent dendritic mRNA transport links filopodial-spine morphogenesis to fragile X syndrome"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.devcel.2008.04.003"
                      "Revista" => array:6 [
                        "tituloSerie" => "Dev Cell"
                        "fecha" => "2008"
                        "volumen" => "14"
                        "paginaInicial" => "926"
                        "paginaFinal" => "939"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            55 => array:3 [
              "identificador" => "bib0280"
              "etiqueta" => "56"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Cell"
                        "fecha" => "2003"
                        "volumen" => "112"
                        "paginaInicial" => "317"
                        "paginaFinal" => "327"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            56 => array:3 [
              "identificador" => "bib0285"
              "etiqueta" => "57"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Fragile X mental retardation protein control of neuronal mRNA metabolism&#58; insights into mRNA stability"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.mcn.2009.09.013"
                      "Revista" => array:6 [
                        "tituloSerie" => "Mol Cell Neurosci"
                        "fecha" => "2010"
                        "volumen" => "43"
                        "paginaInicial" => "43"
                        "paginaFinal" => "50"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            57 => array:3 [
              "identificador" => "bib0290"
              "etiqueta" => "58"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Activation of synaptic group II metabotropic glutamate receptors induces long-term depression at GABAergic synapses in CNS neurons"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1523/JNEUROSCI.0202-13.2013"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Neurosci"
                        "fecha" => "2013"
                        "volumen" => "33"
                        "paginaInicial" => "15964"
                        "paginaFinal" => "15977"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            58 => array:3 [
              "identificador" => "bib0295"
              "etiqueta" => "59"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Targeting the endocannabinoid system in the treatment of fragile X syndrome"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/nm.3127"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nat Med"
                        "fecha" => "2013"
                        "volumen" => "19"
                        "paginaInicial" => "603"
                        "paginaFinal" => "607"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            59 => array:3 [
              "identificador" => "bib0300"
              "etiqueta" => "60"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Fragile X syndrome&#58; loss of local mRNA regulation alters synaptic development and function"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.neuron.2008.10.004"
                      "Revista" => array:6 [
                        "tituloSerie" => "Neuron"
                        "fecha" => "2008"
                        "volumen" => "60"
                        "paginaInicial" => "201"
                        "paginaFinal" => "214"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            60 => array:3 [
              "identificador" => "bib0305"
              "etiqueta" => "61"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The mGluR theory of fragile X mental retardation"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.tins.2004.04.009"
                      "Revista" => array:6 [
                        "tituloSerie" => "Trends Neurosci"
                        "fecha" => "2004"
                        "volumen" => "27"
                        "paginaInicial" => "370"
                        "paginaFinal" => "377"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            61 => array:3 [
              "identificador" => "bib0310"
              "etiqueta" => "62"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Dendritic spine structural anomalies in fragile-X mental retardation syndrome"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Cereb Cortex"
                        "fecha" => "2000"
                        "volumen" => "10"
                        "paginaInicial" => "1038"
                        "paginaFinal" => "1044"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            62 => array:3 [
              "identificador" => "bib0315"
              "etiqueta" => "63"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "MMP-7 disrupts dendritic spines in hippocampal neurons through NMDA receptor activation"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1471-4159.2006.03750.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Neurochem"
                        "fecha" => "2006"
                        "volumen" => "97"
                        "paginaInicial" => "44"
                        "paginaFinal" => "56"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            63 => array:3 [
              "identificador" => "bib0320"
              "etiqueta" => "64"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The GABAA receptor&#58; a novel target for treatment of fragile X&#63;"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.tins.2007.06.003"
                      "Revista" => array:6 [
                        "tituloSerie" => "Trends Neurosci"
                        "fecha" => "2007"
                        "volumen" => "30"
                        "paginaInicial" => "425"
                        "paginaFinal" => "431"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            64 => array:3 [
              "identificador" => "bib0325"
              "etiqueta" => "65"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Towards understanding RNA-mediated neurological disorders"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jgg.2014.08.003"
                      "Revista" => array:7 [
                        "tituloSerie" => "J Genet Genomics"
                        "fecha" => "2014"
                        "volumen" => "41"
                        "paginaInicial" => "473"
                        "paginaFinal" => "484"
                        "link" => array:1 [ …1]
                        "itemHostRev" => array:3 [ …3]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            65 => array:3 [
              "identificador" => "bib0330"
              "etiqueta" => "66"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "RNA-binding proteins hnRNP A2&#47;B1 and CUGBP1 suppress fragile X CGG premutation repeat-induced neurodegeneration in a Drosophila model of FXTAS"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.neuron.2007.07.021"
                      "Revista" => array:6 [
                        "tituloSerie" => "Neuron"
                        "fecha" => "2007"
                        "volumen" => "55"
                        "paginaInicial" => "565"
                        "paginaFinal" => "571"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            66 => array:3 [
              "identificador" => "bib0335"
              "etiqueta" => "67"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Evidence for RNA-mediated toxicity in the fragile X-associated tremor&#47;ataxia syndrome"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "Future Neurol"
                        "fecha" => "2009"
                        "volumen" => "1"
                        "paginaInicial" => "785"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            67 => array:3 [
              "identificador" => "bib0340"
              "etiqueta" => "68"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Mitochondrial dysfunction in fragile X-associated tremor&#47;ataxia syndrome"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J Biol Chem"
                        "fecha" => "2010"
                        "volumen" => "429"
                        "paginaInicial" => "545"
                        "paginaFinal" => "552"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            68 => array:3 [
              "identificador" => "bib0345"
              "etiqueta" => "69"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A novel RNA transcript with antiapoptotic function is silenced in fragile X syndrome"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1371/journal.pone.0001486"
                      "Revista" => array:5 [
                        "tituloSerie" => "PLoS ONE"
                        "fecha" => "2008"
                        "volumen" => "3"
                        "paginaInicial" => "e1486"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            69 => array:3 [
              "identificador" => "bib0350"
              "etiqueta" => "70"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X &#40;FMR1&#41; gene in newborn and high-risk populations"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.2353/jmoldx.2008.070073"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Mol Diagn"
                        "fecha" => "2008"
                        "volumen" => "10"
                        "paginaInicial" => "43"
                        "paginaFinal" => "49"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            70 => array:3 [
              "identificador" => "bib0355"
              "etiqueta" => "71"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Direct molecular analysis of FMR-1 gene mutation in patients with fragile Xq syndrome and their families"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Rev Med Chil"
                        "fecha" => "1998"
                        "volumen" => "126"
                        "paginaInicial" => "1435"
                        "paginaFinal" => "1446"
                         …1
                      ]
                    ]
                  ]
                ]
              ]
            ]
            71 => array:3 [
              "identificador" => "bib0360"
              "etiqueta" => "72"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "An enhanced polymerase chain reaction assay to detect pre- and full mutation alleles of the fragile X mental retardation 1 gene"
                      "autores" => array:1 [ …1]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S1525-1578(10)60594-6"
                      "Revista" => array:6 [ …6]
                    ]
                  ]
                ]
              ]
            ]
            72 => array:3 [
              "identificador" => "bib0365"
              "etiqueta" => "73"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome"
                      "autores" => array:1 [ …1]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1373/clinchem.2009.136101"
                      "Revista" => array:6 [ …6]
                    ]
                  ]
                ]
              ]
            ]
            73 => array:3 [
              "identificador" => "bib0370"
              "etiqueta" => "74"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical screening and FMR1 gene mutation analysis in male patients with Fragile X syndrome"
                      "autores" => array:1 [ …1]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [ …5]
                    ]
                  ]
                ]
              ]
            ]
            74 => array:3 [
              "identificador" => "bib0375"
              "etiqueta" => "75"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Early detection of fragile X syndrome&#58; applications of a novel approach for improved quantitative methylation analysis in venous blood and newborn blood spots"
                      "autores" => array:1 [ …1]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1373/clinchem.2013.217331"
                      "Revista" => array:6 [ …6]
                    ]
                  ]
                ]
              ]
            ]
            75 => array:3 [
              "identificador" => "bib0380"
              "etiqueta" => "76"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Enriched environment promotes behavioral and morphological recovery in a mouse model for the fragile X syndrome"
                      "autores" => array:1 [ …1]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1073/pnas.0504984102"
                      "Revista" => array:6 [ …6]
                    ]
                  ]
                ]
              ]
            ]
            76 => array:3 [
              "identificador" => "bib0385"
              "etiqueta" => "77"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Psychopharmacology in fragile X syndrome&#58; present and future"
                      "autores" => array:1 [ …1]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/mrdd.20007"
                      "Revista" => array:6 [ …6]
                    ]
                  ]
                ]
              ]
            ]
            77 => array:3 [
              "identificador" => "bib0390"
              "etiqueta" => "78"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Aripiprazole in autism spectrum disorders and fragile X syndrome"
                      "autores" => array:1 [ …1]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.nurt.2010.04.001"
                      "Revista" => array:6 [ …6]
                    ]
                  ]
                ]
              ]
            ]
            78 => array:3 [
              "identificador" => "bib0395"
              "etiqueta" => "79"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Advances in the treatment of fragile X syndrome"
                      "autores" => array:1 [ …1]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1542/peds.2008-0317"
                      "Revista" => array:6 [ …6]
                    ]
                  ]
                ]
              ]
            ]
            79 => array:3 [
              "identificador" => "bib0400"
              "etiqueta" => "80"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A double-blind&#44; parallel&#44; multicenter comparison of <span class="elsevierStyleSmallCaps">l</span>-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys"
                      "autores" => array:1 [ …1]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [ …5]
                    ]
                  ]
                ]
              ]
            ]
            80 => array:3 [
              "identificador" => "bib0405"
              "etiqueta" => "81"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical assessment of DSM-IV anxiety disorders in fragile X syndrome&#58; prevalence and characterization"
                      "autores" => array:1 [ …1]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s11689-010-9067-y"
                      "Revista" => array:6 [ …6]
                    ]
                  ]
                ]
              ]
            ]
            81 => array:3 [
              "identificador" => "bib0410"
              "etiqueta" => "82"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Epilepsy in fragile X syndrome"
                      "autores" => array:1 [ …1]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [ …6]
                    ]
                  ]
                ]
              ]
            ]
            82 => array:3 [
              "identificador" => "bib0415"
              "etiqueta" => "83"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Pharmacological treatment of fragile X syndrome with GABAergic drugs in a knockout mouse model"
                      "autores" => array:1 [ …1]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.bbr.2012.01.031"
                      "Revista" => array:6 [ …6]
                    ]
                  ]
                ]
              ]
            ]
            83 => array:3 [
              "identificador" => "bib0420"
              "etiqueta" => "84"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Ganaxolone"
                      "autores" => array:1 [ …1]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.nurt.2006.11.003"
                      "Revista" => array:6 [ …6]
                    ]
                  ]
                ]
              ]
            ]
            84 => array:3 [
              "identificador" => "bib0425"
              "etiqueta" => "85"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Potential therapeutic interventions for fragile X syndrome"
                      "autores" => array:1 [ …1]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.molmed.2010.08.005"
                      "Revista" => array:6 [ …6]
                    ]
                  ]
                ]
              ]
            ]
            85 => array:3 [
              "identificador" => "bib0430"
              "etiqueta" => "86"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Increased GABA &#40;B&#41; receptor mediated signaling reduces the susceptibility of fragile X knockout mice to audiogenic seizures"
                      "autores" => array:1 [ …1]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1124/mol.109.056127"
                      "Revista" => array:7 [ …7]
                    ]
                  ]
                ]
              ]
            ]
            86 => array:3 [
              "identificador" => "bib0435"
              "etiqueta" => "87"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Fragile X and autism&#58; intertwined at the molecular level leading to targeted treatments"
                      "autores" => array:1 [ …1]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1186/2040-2392-1-12"
                      "Revista" => array:6 [ …6]
                    ]
                  ]
                ]
              ]
            ]
            87 => array:3 [
              "identificador" => "bib0440"
              "etiqueta" => "88"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Effects of STX209 &#40;arbaclofen&#41; on neurobehavioral function in children and adults with fragile X syndrome&#58; a randomized&#44; controlled&#44; phase 2 trial"
                      "autores" => array:1 [ …1]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1126/scitranslmed.3004214"
                      "Revista" => array:5 [ …5]
                    ]
                  ]
                ]
              ]
            ]
            88 => array:3 [
              "identificador" => "bib0445"
              "etiqueta" => "89"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A pilot open label&#44; single dose trial of fenobam in adults with fragile X syndrome"
                      "autores" => array:1 [ …1]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1136/jmg.2008.063701"
                      "Revista" => array:6 [ …6]
                    ]
                  ]
                ]
              ]
            ]
            89 => array:3 [
              "identificador" => "bib0450"
              "etiqueta" => "90"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "CTEP&#58; a novel&#44; potent&#44; long-acting&#44; and orally bioavailable metabotropic glutamate receptor 5 inhibitor"
                      "autores" => array:1 [ …1]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1124/jpet.111.185660"
                      "Revista" => array:6 [ …6]
                    ]
                  ]
                ]
              ]
            ]
            90 => array:3 [
              "identificador" => "bib0455"
              "etiqueta" => "91"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome"
                      "autores" => array:1 [ …1]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/DBP.0b013e31817dc447"
                      "Revista" => array:6 [ …6]
                    ]
                  ]
                ]
              ]
            ]
            91 => array:3 [
              "identificador" => "bib0460"
              "etiqueta" => "92"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model"
                      "autores" => array:1 [ …1]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1136/jmg.2008.061796"
                      "Revista" => array:6 [ …6]
                    ]
                  ]
                ]
              ]
            ]
            92 => array:3 [
              "identificador" => "bib0465"
              "etiqueta" => "93"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Open-label add-on treatment trial of minocycline in fragile X syndrome"
                      "autores" => array:1 [ …1]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1186/1471-2377-10-91"
                      "Revista" => array:6 [ …6]
                    ]
                  ]
                ]
              ]
            ]
            93 => array:3 [
              "identificador" => "bib0470"
              "etiqueta" => "94"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Treatments for fragile X syndrome&#58; a closer look at the data"
                      "autores" => array:1 [ …1]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/ddrr.78"
                      "Revista" => array:7 [ …7]
                    ]
                  ]
                ]
              ]
            ]
            94 => array:3 [
              "identificador" => "bib0475"
              "etiqueta" => "95"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A review of fragile X premutation disorders&#58; expanding the psychiatric perspective"
                      "autores" => array:1 [ …1]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.4088/JCP.08m04476"
                      "Revista" => array:6 [ …6]
                    ]
                  ]
                ]
              ]
            ]
            95 => array:3 [
              "identificador" => "bib0480"
              "etiqueta" => "96"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Symptomatic treatment in the fragile X-associated tremor&#47;ataxia syndrome"
                      "autores" => array:1 [ …1]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/mds.21001"
                      "Revista" => array:7 [ …7]
                    ]
                  ]
                ]
              ]
            ]
            96 => array:3 [
              "identificador" => "bib0485"
              "etiqueta" => "97"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Widespread non-central nervous system organ pathology in fragile X premutation carriers with fragile X-associated tremor&#47;ataxia syndrome and CGG knock-in mice"
                      "autores" => array:1 [ …1]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s00401-011-0860-9"
                      "Revista" => array:6 [ …6]
                    ]
                  ]
                ]
              ]
            ]
            97 => array:3 [
              "identificador" => "bib0490"
              "etiqueta" => "98"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Memantine effects on verbal memory in fragile X-associated tremor&#47;ataxia syndrome &#40;FXTAS&#41;&#58; a double-blind brain potential study"
                      "autores" => array:1 [ …1]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/npp.2014.122"
                      "Revista" => array:6 [ …6]
                    ]
                  ]
                ]
              ]
            ]
            98 => array:3 [
              "identificador" => "bib0495"
              "etiqueta" => "99"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Genetic counseling for fragile X syndrome&#58; updated recommendations of the National Society of Genetic Counselors"
                      "autores" => array:1 [ …1]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s10897-005-4802-x"
                      "Revista" => array:6 [ …6]
                    ]
                  ]
                ]
              ]
            ]
            99 => array:3 [
              "identificador" => "bib0500"
              "etiqueta" => "100"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical guideline of gene FMR1-associated diseases&#58; fragile X syndrome&#44; primary ovarian insufficiency and tremor-ataxia syndrome"
                      "autores" => array:1 [ …1]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [ …5]
                    ]
                  ]
                ]
              ]
            ]
            100 => array:3 [
              "identificador" => "bib0505"
              "etiqueta" => "101"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Screening for fragile X syndrome in women of reproductive age"
                      "autores" => array:1 [ …1]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [ …6]
                    ]
                  ]
                ]
              ]
            ]
            101 => array:3 [
              "identificador" => "bib0510"
              "etiqueta" => "102"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Newborn screening for fragile X syndrome"
                      "autores" => array:1 [ …1]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/jamaneurol.2013.4808"
                      "Revista" => array:6 [ …6]
                    ]
                  ]
                ]
              ]
            ]
            102 => array:3 [
              "identificador" => "bib0515"
              "etiqueta" => "103"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Fragile X&#58; a family of disorders"
                      "autores" => array:1 [ …1]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.yapd.2009.08.008"
                      "Revista" => array:6 [ …6]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/21735808/0000003200000004/v1_201704190057/S2173580816301249/v1_201704190057/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "9423"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Review articles"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/21735808/0000003200000004/v1_201704190057/S2173580816301249/v1_201704190057/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173580816301249?idApp=UINPBA00004N"
]
Article information
ISSN: 21735808
Original language: English
DOI:10.1016/j.nrleng.2014.10.018
The statistics are updated each day
Year/Month Html Pdf Total
2024 October 44 10 54
2024 September 86 12 98
2024 August 62 3 65
2024 July 48 10 58
2024 June 56 5 61
2024 May 53 8 61
2024 April 67 28 95
2024 March 98 8 106
2024 February 85 13 98
2024 January 134 18 152
2023 December 119 17 136
2023 November 119 28 147
2023 October 159 15 174
2023 September 75 15 90
2023 August 73 15 88
2023 July 85 11 96
2023 June 103 26 129
2023 May 121 15 136
2023 April 96 14 110
2023 March 74 8 82
2023 February 44 10 54
2023 January 48 7 55
2022 December 59 15 74
2022 November 50 4 54
2022 October 38 29 67
2022 September 40 31 71
2022 August 31 14 45
2022 July 28 13 41
2022 June 27 10 37
2022 May 22 12 34
2022 April 37 10 47
2022 March 36 14 50
2022 February 150 8 158
2022 January 30 19 49
2021 December 142 14 156
2021 November 52 29 81
2021 October 60 24 84
2021 September 46 18 64
2021 August 39 21 60
2021 July 31 10 41
2021 June 39 20 59
2021 May 36 12 48
2021 April 170 24 194
2021 March 83 11 94
2021 February 64 6 70
2021 January 44 11 55
2020 December 60 18 78
2020 November 42 18 60
2020 October 30 3 33
2020 September 37 17 54
2020 August 30 10 40
2020 July 34 21 55
2020 June 27 8 35
2020 May 38 22 60
2020 April 41 9 50
2020 March 17 5 22
2020 February 30 11 41
2020 January 39 16 55
2019 December 24 11 35
2019 November 11 9 20
2019 October 16 5 21
2019 September 25 9 34
2019 August 13 5 18
2019 July 36 20 56
2019 June 42 32 74
2019 May 80 38 118
2019 April 44 28 72
2019 March 26 4 30
2019 February 42 13 55
2019 January 41 10 51
2018 December 39 13 52
2018 November 51 68 119
2018 October 59 16 75
2018 September 33 4 37
2018 August 44 5 49
2018 July 37 4 41
2018 June 31 6 37
2018 May 51 6 57
2018 April 74 14 88
2018 March 16 5 21
2018 February 185 5 190
2018 January 122 0 122
2017 December 190 9 199
2017 November 122 4 126
2017 October 20 9 29
2017 September 20 2 22
2017 August 23 7 30
2017 July 24 3 27
2017 June 18 24 42
2017 May 39 12 51
2017 April 11 10 21
2017 March 6 17 23
2017 February 2 3 5
2017 January 1 4 5
2016 December 0 2 2
Show all

Follow this link to access the full text of the article

Subscribe to our newsletter

Publish in
Neurología

Neurología (English Edition) follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos